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CHAPTER 1

INTRODUCTION

1.1 Basic Bone Physiology
Bone is a highly mineralized supporting frame of the body which is characterized by its
mechanical stability, ability to regenerate and repair. In addition to protecting the role of vital
organs, it provides an environment for marrow regarding blood formation and fat storage. One of
the most critical roles of bone is to act as a mineral reservoir for calcium homeostasis and a
reservoir of growth factors and cytokines, and also to maintain acid-base balance [1]. Bone
continuously undergoes modeling and remodeling during our life span. This process is essential in
order to change biomechanical forces, remodel or remove old bone and replace it with new,
stronger bone tissue to help preserve its strength.

1.1.1 Bone Structure
Generally, bone is made up of: I. Inorganic (~69 %) component, mostly consisting of
hydroxyapatite (~99 %) II. Organic (~22 %), constituted by collagen (~90 %) and non-collagen
structural proteins. The functional component of the bone includes growth factors and cytokines.
The hardness and rigidity of bone are due to the presence of mineral salt in the osteoid matrix,
which is a crystalline complex of calcium and phosphate (hydroxyapatite). Calcified bone contains
~25 % organic matrix, 5 % water, and 70 % inorganic mineral (hydroxyapatite). Collagen I
constitute 90–95 % of the organic matrix of bone (Figure 1.1). Osteoblasts synthesize and lay
down precursors of collagen I [2]. They also produce osteocalcin, which is the most abundant non-
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collagenous protein of bone matrix, and the proteoglycans of ground substance. The collagen I
formed by osteoblasts is deposited in parallel or concentric layers to produce mature (lamellar)
bone. When the bone is rapidly formed, as in the fetus or certain pathological conditions (e.g.,
fracture callus, fibrous dysplasia, hyperparathyroidism), the collagen is not deposited in a parallel
array but in a basket-like weave resulting in woven, immature, or primitive bone. Osteoblasts also
synthesize and secrete non-collagenous protein, such as proteoglycans, glycosylated proteins,
glycosylated proteins with potential cell-attachment activities, and g-carboxylated (gla) proteins.
The main glycosylated protein present in bone is alkaline phosphatase, which plays an as-yetundefined role in mineralization of bone [3].

Water
15%

Organic
Substances
25%
Inorganic Substances

Inorganic
Substances
60%
Organic Substances

Water

Figure 1.1. Bone composition
1.1.2 Bone Modeling & Remodeling
Bone consists of support cells; osteoblasts and osteocytes, remodeling cells; osteoclasts,
and non-mineral matrix of collagen and non-collagenous proteins called osteoid, with inorganic
mineral salts deposited within the matrix. During life, the bones undergo processes of the
longitudinal and radial growth, modeling, and remodeling [4]. Longitudinal growth occurs at the
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growth plates, where cartilage proliferates in the epiphyseal and metaphyseal areas of long bones,
before subsequently undergoing mineralization to form primary new bone.

1.1.3 Current Bone Regeneration Strategies
Based on the type of bone loss, many options are possible. Currently, the standard bone fillers
are autografts, allografts, and synthetic bone fillers. Due to limitation on autogenous bone
availability in a patient, especially in pediatric patients and the elderly, and allografts fatal
infection, the autografts and allografts use are limited [5-7].
From a synthetic bone substitute point of view, biodegradable calcium phosphates offer
superior biocompatibility (resembling the mineral phase of bone) and, in many instances, a more
readily controlled antibiotic release [8]. Therefore, for the purposes of subsequent recovery of
bone, there is strong interest in calcium phosphate-based carrier development. Calcium phosphate
cement (CPC) has been widely used as synthetic bone graft by injecting it into the bone defect
area.
Owing biocompatible, osteoconductive and biodegradable nature; [9] calcium polyphosphate
(CPP) has been studied for use in cartilage and bone repair, as well as for angiogenesis [9-13]. In
addition, some of the studies have been done to develop low-temperature fabrication protocols for
the inclusion of thermal-labile biological agents in CPP. Further the potential of this material for
local drug delivery has been investigated [14-16]. This chapter intended to highlight the problem
statement, possible solutions and some of the structural and in vitro properties of CPP that may
impact its potential to serve as a carrier in a local delivery system.
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1.2 Problem Statement: Osteomyelitis
1.2.1 Pathophysiology
Chronic osteomyelitis is an infection of the bone that does not result from acute
hematogenous seeding or penetrating injury and usually occurs by contiguous spread and has been
present for several weeks. In osteomyelitis cases, staphylococcus aureus is the most pathogenic;
it typically causes skin infections and sometimes pneumonia, endocarditis, and osteomyelitis. It
commonly leads to abscess formation. However, healthy bone is highly resistant to infection, upon
implantation or surgical procedures, bacterial can reach the bone and cause inflammation.
Advancement of infection to the rigid limitations of the marrow space causes reduction of blood
flow provides an ideal site for bacteria to settle, and will eventually lead to local vascular occlusion
and thrombosis as the inflammatory response grows.
Consequently, bone necrosis and the development of local sequestra are leading a
complicated anatomical site to treat by systemic antibiotic delivery [5-8].

1.2.2 Treatment Options
Effective treatment of osteomyelitis can be achieved by addressing three interacting
components: 1) anatomic stability, 2) microbiological virulence, and 3) host physiology [9]. A
combination of antibiotic delivery and surgical approaches may be considered for addressing all
osteomyelitis cases [10-12].
The standard method to overcome osteomyelitis consists of debridement, dead space
management, and a prolonged antibiotics administration. Surgical debridement is an essential first
step in treating this disease. It reduces bacterial load, removes necrotic tissue and visible sequestra,
and potentially allows for the apposition of healthy bone, though not without temporarily causing
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some destabilization of the site [9]. Additional to surgical debridement and dead space
management, antibiotics are traditionally administered systemically for at least six weeks [11-13].
However, as 6 weeks of systemic antibiotic administration is insufficient in many cases of chronic
osteomyelitis [14, 15] and there is a growing concern over antimicrobial resistance development
with prolonged antibiotic presence [10], therefore introducing a carrier for localized delivery of
antibiotics come to play a critical role. This strategy may achieve elevated antibiotic concentrations
at the site of infection and limit the side effects and risk of overdose otherwise seen with
systemically administered therapeutics, as well as offer additional therapeutic value by supporting
bone restoration. Although CPC materials are biocompatible and set isothermally, they have some
drawbacks regarding mechanical stability and drug burst release. The initial reason for these
limitations refers to weak binding mechanism of hydroxyapatite with drug [16]. As previously
discussed more complexity of material prolongs drug release. A unique class of calcium phosphate,
calcium polyphosphate (CPP) may offer an advantage in this regard as it resembles a polymeric
compound and can make complex with drugs. The partial objective of this research is to examine
CPP capacity to act as a local delivery system for treatment of osteomyelitis, and subsequently
effect of CPP on DCPD formation and drug delivery capacity of newly developed P-DCPD.

1.2.3 Antibiotics Studied for Localized Osteomyelitis Treatment
Vancomycin (VCM) and erythromycin (EM), with minimum inhibitory concentration
(MIC); 2 mg/L, are two antibiotics of choice in this study.
VCM is water-soluble and stable in body temperature. As a tricyclic glycopeptide
antibiotic, VCM reportedly inhibits cell wall peptidoglycan synthesis in gram-positive bacteria
[17]; by preventing DNA, RNA, and protein synthesis it will in time lead to the death of the
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bacterial cell. Furthermore, VCM has shown fewer negative effects on osteoblasts in vitro and
should be less likely to impede bone growth than other commonly used antibiotics [18-20].
EM is an antibiotic from macrolide family which suppressing bacterial growth by
inhibiting crucial proteins for bacterial function. EM is stable in body temperature but it belongs
to the hydrophobic category of antibiotics agents. EM is broadly used to treat infections caused by
various bacteria, including S. aureus[21]. The first use of EM in clinical setting dated back to the
early 1950s. In addition to direct targeting against bacteria, EM also helps with bacterial infection
symptoms by suppressing inflammation [22, 23]. EM has been shown to reduce the production of
pro-inflammatory cytokines in various scenarios [24, 25]. While S. Aureus frequently evolves to
acquire resistance to antibiotic treatment, the combination of EM with other antibiotics or herbal
medicines seems to be able to overcome this difficulty and results in a synergistic effect in
suppressing bacterial growth [26]. Interestingly, although the efficacy of EM has been reported in
various scenarios, its role in treating Methicillin-resistant Staphylococcus aureus (MRSA) induced
osteomyelitis is not well documented.
This dissertation, including both hydrophilic and hydrophobic antibiotics leads to a better
understanding of interaction between fully hydrated polyphosphate chains of ACPP with these
therapeutics.

7

a

b

Figure 1.2. Molecular schematic of a) EM: C37H67NO13 and b) VCM: C66 H75 Cl2 N9 O24 (adapted
from PubChem)

Table 1.1. Chemical properties of EM and VCM
Erythromycin (EM)

Vancomycin (VCM)

Molecular Weight (g/mol) pkA

Molecular Weight (g/mol)

pkA
2.6, 7.7, 8.6, 9.6,

733.93

8.6 - 8.8[27, 28]

1449.265
10.5, 11.7

The molecular structure of VCM (Figure 2.2) consists of 18 chiral centers surrounding
three “cavities” that are bridged by five aromatic rings [29]. This antibiotic is able to have strong
polar interactions with solutes likely as a result of the strong polar groupsproximate to the ring
structures.
These groups include a carboxyl group (pKa of 2.18), a primary amino group (pKa of 7.75),
a secondary amino group (pKa at 8.89) and three phenol groups (pKa of 9.59, 10.40, 12.00)
[29].The two amino groups have basic properties, while the carboxyl and phenol groups are more
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acidic. The net positive charge of VCM across a 0 to 13 pH range is varied: it is +2.1 at pH of 2,
+0.7 at a pH of 3-7.4, and +4.0 at a pH of 13[29]. The unique size and structure of VCM may
impact how this antibiotic is loaded and released from the CPP-based local delivery system. For
example, owing to VCM being a large molecule and potentially having some chemical steric
hindrance, strong evidence has been presented that any chemical interaction between this antibiotic
and calcium phosphate materials is limited [30-33]. Instead, the loaded VCM interacts with
calcium phosphate materials via physical adsorption and, as a result, the manner in which VCM is
incorporated into a calcium phosphate material is of particular importance [34, 35]. VCM is a
hydrophilic molecule with a molecular size of around 1.8 nm [36].
The molecular structure of EM consists of 14 lactone ring. EM is an antibiotic that belongs
to the group of macrolide antibiotics. The structural characteristic of macrolides, to which EM
affiliates, is a macrocyclic lactone ring of fourteen, fifteen or sixteen members. Substituents on the
main chain are cladinose on C-3 and desosamine on C-5. EM is not a single compound but
represents an alloy of structural very similar components. EM is hydrophobic molecule with a size
of 1.6 nm [37].

1.3 Currently Studied Biodegradable Carrier Materials for Localized Osteomyelitis Therapy
Biodegradable delivery vehicles have been the focus of recent local therapy research and
are of interest in the doctoral research presented here largely as they eliminate the need for
reoperation and removal following treatment [38-44]. Also owing to its eventual degradation, a
biodegradable carrier is not as limited by the size or type of antibiotic that may be loaded and
offers greater antibiotic availability than that possible with PMMA. Biodegradable carrier
materials of interest include natural polymers such as collagen (e.g. CollatrampG® and
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Septocol®E), and bone graft substitutes including calcium sulphate (e.g. Herafill®, Osteoset®T),
bioactive glass (e.g. Bioglass®, BonAlive®), and calcium phosphate (e.g. Vitoss®,
Bonesource®). Disadvantages of collagenous and calcium sulfate carriers include the high risk of
seroma formation (i.e. an accumulation of serum) and burst release owing to a ready absorption of
large amounts of water into these materials [45-48]. For synthetic aliphatic polyester polymers, the
most significant disadvantage is the potential for bone resorption during carrier degradation
[47].With bioactive glass matrices the processing control is more complex and has, to date, limited
their application for drug delivery [47, 49]. For example, conventional organic compounds used
to create porosity within the Bioglass® matrices cannot be readily removed upon heat treatment
[50]. Furthermore, despite the relative interest in many of the aforementioned carriers, there is a
lack of knowledge to evaluate their relative value in treating chronic osteomyelitis [48]. As a result,
there are still many carriers awaiting FDA approval for use as an antibiotic delivery vehicle.
Commercially available applications in osteomyelitis treatment remain sparse and much research
is still required in this field.
Based on studied carriers, biodegradable calcium phosphates offer superior
biocompatibility (owing to chemistry resembling the mineral phase of bone) and, in many
instances, a more readily controlled antibiotic release [48]. Therefore, for the purposes of
osteomyelitis therapy and subsequent recovery of bone, there is strong interest in calcium
phosphate-based carrier development. A unique class of calcium phosphate, calcium
polyphosphate (CPP) may offer an advantage in this regard as it possesses some potentially unique
drug delivery-relevant attributes of its own.
Owing to its biocompatible, osteoconductive and biodegradable nature [51-53], CPP has
been studied for use in cartilage and bone repair, as well as for angiogenesis [51, 54-57]. In
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addition, recent progress in the development of low-temperature fabrication protocols for the
inclusion of thermal-labile biological agents in CPP has further supported the potential of this
material for local drug delivery[43, 58, 59]. The next section highlights some of the structural and
in vitro properties of CPP that may impact its potential to serve as a local drug delivery system.

1.4 Calcium Polyphosphate (CPP) Hydrogel
1.4.1 CPP Structure
Structural properties of polyphosphate glasses are more dependent on the P-O-cation
interchain bonding than the nature of the P-O-P bonds that form the phosphate chain [60]
The phosphate structure consists of phosphorus atom surrounded by four oxygen atoms
arranged at corners of a tetrahedron; this satisfies Zachariasen’s criteria [60, 61]; Interconnected
PO4 tetrahedra are then produced when these oxygen atoms are shared via covalent bonds [61].
These basic building blocks of phosphate are classified following Qi terminology, where “i"
indicates the number of bridging oxygen per tetrahedral.

Figure 1.3. Qi phosphate tetrahedral species [60]
The phosphate species include Q0 as an orthophosphate ion, Q1 as a pyrophosphate or chain end
group, Q2 as an internal phosphate group, and Q3 as a branched phosphate group. By combining
the end groups, middle groups, and branching points a number of different phosphate networks
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can be formed. Of interest in this thesis is a linear long-chain phosphate structure that consists
mainly of the Q2 species. As a result of the high charge associated with the tetrahedral anions,
phosphates tend to associate strongly with cations under most conditions [61]. CPP itself consists
of long polymeric chains of phosphate connected via covalent bonds and “chelated” calcium (Ca)
ions as network modifiers/connectors between chains [62, 63].

1.4.2 CPP In Vitro Properties
The sharing of available oxygen atoms alters the environment around the calcium ions in
a way that, upon contact with water, there is a competition between the oxygen from terminal
phosphate groups and water to bond with calcium ions. Continued exposure to aqueous media
encourages the gradual degradation of CPP by two interdependent steps: (1) the exchange of
calcium ions in CPP with hydrogen ions from the media, resulting in the formation of a hydrated
layer at the interface between CPP and media, and (2) the network breakage of P-O-P bonds under
the attack of hydrogen ions and water molecules [44, 63-67]. Fully hydrated phosphate chains
disentangle from partially hydrated chains still attached to the surface and leach into the solution
[66]. Hydrolytic degradation in the presence of calcium occurs significantly at the inner P-O-P
linkages and continues to produce shorter and shorter polyphosphate chains [68, 69]. However,
alternative degradation paths include splitting of end PO4 groups and, to a lesser degree, ring
formation (e.g. tri- and tetra-metaphosphate) [69, 70]. Depending on the solution pH, as CPP
degradation continues beyond several days precipitates such as Ca3(HP2 O7)2*4H2O and
Ca(H2PO4)2 start to form [70]. Overall, longer chains do not release the orthophosphate as quickly
as shorter chains, pH will not drop as quickly, and there will be fewer preferable sites for chain
scission with a reduced degradation rate compared to short molecular chains [67]. Increasing the

12

chain length of CPP, then, maybe one useful approach to further control the degradation of the
carrier and release of the loaded antibiotic in vitro.

1.4.3 CPP Synthesis
CPP can be fabricated to give phosphate glass or crystalline material by manipulating the
processing parameters and starting compounds used. In the proposed studies, the CPP glass is the
material of interest. According to the literature, the most common method for fabricating
amorphous CPP is directly from phosphate melts following prior condensation of a starting
calcium phosphate hydrate [71].The heat ramp rates, temperatures, and dwell times of calcination
are important parameters to consider when synthesizing CPP from a calcium phosphate monobasic
monohydrate (CPMM) (i.e. Ca(H2PO4)2*H2O). These parameters need to be of sufficient
magnitude in order to drive off the crystalline water and initiate condensation and to, subsequently,
further polymerize the phosphates[67, 71]. In this proposal we always synthesize ACPP using
aforementioned protocol[72], briefly; Calcium phosphate monobasic monohydrate, (Ca[H2PO4]2
.

H2O; Sigma-Aldrich, St. Louis, MO) were calcined for 10 hours at 500°C followed by melting

for 1 hour at 1200°C to produce an amorphous glass and quenching at room temperature for
cooling. The resulting material was hammered to make small particles prior to grind in a planetary
ball mill (Across International, Berkeley, NJ). The resulting particles were sieved (Laboratory Test
Sieves, Fisher Scientific, Pittsburg, PA) continuously to segregate particles less than 75 µm. Prior
to usage, ACPP powders were stored in a vacuum desiccator to avoid moisture absorption.

1.5 Matrix Fabrication Strategy for Localized Osteomyelitis Therapy
1.5.1 Current Status in the Literature
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One of the greatest challenges in designing drug delivery systems is how to load the drug in a
way that retains its activity as well as maintaining all necessary scaffold characteristics for optimal
elution. As traditional ceramics processing involves the consolidation of powders by molding and
sintering, the high temperatures involved prevent the loading of the drug until the shaping of the
final implant has been completed [73]. Various techniques have been used to incorporate a
therapeutic agent with a pre-made calcium phosphate biomaterial [34]. These techniques include
powder-powder mixing [74-76], adsorption of agent on the biomaterial following some degree of
solution soaking, and centrifugation of solution into porous construct. These methods face some
limitations due to relatively fast therapeutic release common to many of these approaches. The
matrix design presented in this research takes advantage of fully hydrated and moldable amorphous
CPP to create a delivery device with sustained release.
For several years our research group has sought to exploit the unique protocol of making
hydrogel from CPP glass to achieve more robust therapeutic loading with the more controllable
and sustained antibiotic release [72]. Due to the chelation of calcium ions to the phosphate chains
of CPP, any exposure to water molecules is believed to cause a preferential bonding of hydrogens
to the protons already connected to the non-bridging-oxygen atoms [62, 63]. One early theory
proposed by Dion et. al., based on this behavior of CPP in high humidity, suggested that the
solvation or hydrolysis, then condensation, and, lastly, drying steps involved in gelling of CPP
could create an altered polyphosphate structure [43]. In this method, they were able to reduce the
burst release of VCM from the gelled amorphous CPP disks and extend the therapeuticallyrelevant release period compared to un-gelled disks to six days. However, despite greater sample
densities observed in the internal regions of the gelled samples compared to non-gelled samples,
the disk tensile strength decreased with increased gelling time until a minimum of 0.411MPa was
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reached following 48 hours of gelling [43, 58]. This was believed to be due to the congruent
creation of larger pores at the surface of the disks with longer exposure to humidity, and the
changing distribution of pores and pore sizes throughout the bulk of the disk. The uneven
distribution of pores also likely contributed to the still present, though reduced, burst release.
Currently, in our research group, a new method to prepare CPP hydrogel was introduced. In this
method, polyphosphate chains become fully hydrated by exposing to water. As it has been noted
in previous studies on this hydrogel, because of the numerous advantages of CPP hydrogel, it can
take place of monomeric calcium phosphate in forming calcium phosphate cement (CPC). The
resulting cement is called “polymeric dicalcium phosphate dihydrate” (P-DCPD).

1.5.2 Novel P-DCPD Bone Cement
Calcium phosphate cement (CPC) is promising for clinical applications due to their
advantageous properties including bioactivity, osteoconductivity, injectability, and moldability.
The discovery of the first CPC occurred via the observation of calcium phosphate solubility
behavior [77]. The self-setting reaction is usually based on the freshly prepared mixtures of
monomeric calcium phosphate powders, such as acidic monocalcium phosphate monohydrate
(MCPM) and basic calcium phosphates (e.g., tetracalcium phosphate, TTCP) with an aqueous
solution, which undergo setting in a continuous dissolution–precipitation reaction [77, 78]
.Various mixtures of calcium and phosphate, basically produce two cement types [79]:
hydroxyapatite (HA), and dicalcium phosphate dihydrate. CPC is biodegradable in vivo and
replaced by new bone tissue [80, 81]. DCPD forming cement degrade much faster than HA
forming cement. Many studies have demonstrated the bone remodeling capacity of such cement
in various animal models within a time period of 8–52 weeks [82-84]. CPCs are commonly used
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to repair bone defects due to their good biocompatibility and isothermally setting reaction.
However, the clinical application of CPCs has been greatly limited because of their inherent low
mechanical strength [78, 85] and poor cohesion [78, 86]. Many efforts have been applied to CPC
granules modification [87, 88]. Some actions have been taken to increase CPC mechanical strength
to modify the cement liquid with some polymeric materials such as collagen [89, 90], the use of
dual-setting cement in which a dissolved monomer is simultaneously cross-linked during cement
setting [85, 91]. The other kind of modification refers to dual-setting system applying polymeric
compounds, in a way that can be cross-linked by binding calcium ions in the polymer chain, e.g.,
polyacrylic acid. In these methods, polymers bind through dissolution–precipitation mechanism as
well as deprotonating the organic acid following the formation of intra- or inter-chained bonding
Ca2+–Acid chelates. One of the most important concerns regarding this organic polymer-based
dual-setting system is the toxicity of non-degradable additives (fibers, polymers). In addition after
40 years, there are still limitations in generating effective methods to overcome weak mechanical
strength and poor cohesion of CPCs [78]. Basically, Polyphosphates are polyelectrolytes that play
major roles in biological and material science [92, 93]. Calcium polyphosphate (CPP) is composed
of linear polyphosphate chains with Ca/P ratio of 0.5. CPP is easily hydrolyzed into the naturallyoccurring calcium orthophosphate [71, 72]. Recent studies, including our research group’s work,
found that CPP represents a promising bone substitute because of its biocompatibility [62],
mechanical strength, and stimulation of bone healing [71, 94]. The unique structure of CPP allows
CPP to behave as an inorganic polymer to some extent [95]. In this study, CPP was prepared in
amorphous structure rather than any crystalline structure (gamma-, beta-, or alpha-phase).
Recently, it has been found that CPP gel can be formed by soaking amorphous CPP (ACPP)
in the presence of water [72]. The increased water availability accelerates the water molecule
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ingress and microstructural transformation of CPP gels. In our research group by using Raman
spectroscopy, it has been demonstrated that the mechanism of CPP gelation is mainly due to the
bridging network between linear polyphosphate chains and calcium (Ca2+) in the water and
entanglement of polyphosphate chains [72]. In another attempt in our research group, a novel and
simple method to prepare injectable and self-setting P-DCPD cement by the reaction of CPP gel
with tetracalcium phosphate (Ca4(PO4)2O, TTCP) were described. In contrast to the classical CPC
setting formula (reaction of monomeric acid calcium source with alkali calcium source) [78], Song
et. al. used CPP gel as the acidic calcium source. They found that the setting mechanism of PDCPD is completely different from the classical calcium phosphate cement (CPC) that achieves
crystallization by monophosphates reaction. P-DCPD introduces a new type of poly-CPCs with
some superiorities, including strong mechanical strength, excellent cohesion and easy of handling.
More extensive experiments to further evaluate the performance of P-DCPD cement, including
biocompatibility and degradation behavior, were addressed here.

1.6 Summary of Dissertation & Specific Aims
My goal is to comprehensively investigate physicochemical properties and bioactivity of
CPP hydrogel itself as well as P-DCPD forming cement. Thus, in the previous studies, our group
developed and characterized CPP hydrogel [72]. Further in Chapter 2, I study the drug delivery
capacity of CPP hydrogel to determine whether fully hydrated polyphosphate chains improve
antibiotics encapsulation to address a fairly common burst release issue. I test various factors that
impact drug loading efficacy. Investigation on parameters such as antibiotics’ chemical structure
(hydrophobic and hydrophilic), incorporation techniques (powder or gel), and finally change in
viscoelastic properties of ACPP gel with and without antibiotics, is valuable in terms of taking one
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step toward improvement of antibiotic incorporation in the bone infection area. In Chapter 3, I
study antibacterial response of P-DCPD cement loaded with antibiotics in agar plate. In this way
the bacterial inhibition area is measured and the effect of antibiotic retained within the bone
cement is tested. In Chapter 4, the classical DCPD cement that was upgraded by CPP hydrogel
instead of monomeric calcium phosphate material is under investigation by developing a series of
characterization experiments. Physiochemical variations between DCPD and P-DCPD is fully
understood. Individually, I perform a series of characterization measurements such as; Raman
spectroscopy, contact angle, zeta potential, and pH measurements of P-DCPD and DCPD particles.
As the last and most important piece in the puzzle of understanding the P-DCPD qualification as
a biocompatible bone cement material, in Chapter 5, I conduct in Vitro and in Vivo
biocompatibility study of P-DCPD and DCPD, physiochemical differences (Chapter 4) may play
an important role in biocompatibility characteristics of these materials.

1.6.1 Specific Aim 1: Develop a Strategy to Study Antibiotics Effect on Structural and
Physiochemical Properties of Calcium Polyphosphate Matrix
In this aim, we study the nature of any physiochemical interaction between EM/VCM and
ACPP hydrogel.
Hypothesis: Antibiotics interact with a fully hydrated ACPP matrix by physical and ionic
interaction which leads to delayed antibiotic release.
a) Antibiotic loading comparison for two incorporation methods demonstrates the role of fully
hydrated polyphosphate chains in antibiotic-hydrogel interaction
b) Raman Spectroscopy and identify molecular-level interaction between antibiotics and ACPP
hydrogel
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c) Viscoelastic properties of ACPP hydrogel was affected upon antibiotic incorporation
d) Antibiotics release mechanism from ACPP hydrogel further confirms the interaction between
antibiotics and hydrogel
e) Antibacterial activity of released antibiotics depends on the sensitivity of antibiotics to the
elution medium.

1.6.2 Specific Aim 2: Antibacterial Activity of Polymeric Dicalcium Phosphate Dihydrate (PDCPD) Loaded with Antibiotics
Next, I implement, for the first time, antibiotics within P-DCPD bone cement by 2
approaches. Mix antibiotic with ACPP hydrogel first and the add complementary powders to
prepare P-DCPD bone cement. In second approach I add antibiotic powder to complementary
powder portion of P-DCPD cement and then add ACPP hydrogel. In this way I investigate which
way more effectively retains antibacterial activity of antibiotics during the Agar plate experiment.
made by ACPP hydrogel would be tested for antibiotic interaction with material and its activity
stage. I measure the bacteria growth inhibition area by diffused antibiotics from P-DCPD cement
discs using Kirby-Bauer method.
Hypothesis: P-DCPD antibiotic preserves the antibacterial activity of VCM and EM due
to neutral pH of release medium higher than what has been reported for CPP hydrogel.
a)

b)

Preparing P-DCPD discs loaded with antibiotics using two methods
•

Antibiotic mixed with ACPP hydrogel

•

Antibiotic mixed with sodium citrate and TTCP powder

Antibacterial activity of P-DCPD thin disc using Kirby_Bauer method
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1.6.3 Specific Aim 3: Physiochemical Comparison of DCPD and P-DCPD
Previously a study was conducted to reveal P-DCPD advantages over DCPD material in
terms of mechanical stability, cohesion and handling properties. I conduct, contact angle, Raman
spectroscopy, zeta potential, and pH measurements on mature DCPD and P-DCPD particles to
understand the setting mechanism and morphology of particles.
Hypothesis: P-DCPD particles (<75 µm) as a new self-setting reaction system is
completely different from the classical DCPD (<75 µm) setting-reaction system that achieves
crystallization by monophosphates reaction. Also upon addiction of citrate to PDCPD handling
properties, mechanical stability represents a new type of poly-CPCs with significant advantages
over current CPC products.
a) To differentiate the particles, Scanning Electron Microscopy (SEM) and Energy Dispersive
Spectroscopy (EDS) were utilized to characterize the particles’ morphology and Ca/P ratio.
b) Dynamic change of bonding (vibrational) mechanism through incubation times were studied by
Raman spectroscopy
c) Phase changes and molecular identification were investigated through XRD
d) Measurement of net charge of particles in H2O immersion has been conducted using Zeta
Potential
e) Relative surface hydrophilicity and absorbance rate is another important factor for the cement
to be qualified as a favorable material for cell attachment, which can be measured by a surface
contact angle.

1.6.4 Specific Aim 4: Biocompatibility comparison studies of P-DCPD and DCPD in Vitro
and in Vivo
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The growth and differentiation of different cells need appropriate microstructures of ECM.
However, it is still unclear how the cells choose and what kinds of microstructures the specified
cells prefer. After defining the physicochemical properties of ACPP and P-DCPD, we should be
able to investigate the cellular behaviors of these well-defined materials.
More importantly, after in vitro biocompatibility testing, and in vivo biocompatibility study
for testing tissue response on both P-DCPD and DCPD scaffolds is needed. As such, for further
extending the results to show P-DCPD performance in a mouse air pouch model, I design an animal
study with different steps, based on my hypothesis.
Hypothesis: Several factors such as surface charge, microporosity, composition and
changes of molecular composition, affect osteoblast cell adhesion and migration process to the
surface. Based on preliminary results from physiochemical differences between DCPD and PDCPD, it is expected that cells behave differently in terms of proliferation and differentiation on
each material. Based on previously studied unique properties of P-DCPD and DCPD, mouse air
pouch tissue represents different inflammatory responses.to support our hypothesis we performed
bellow steps;
a) One key requirement for calcium phosphate materials to be bioactive and bond to the living
bone is the formation of a bone-like apatite layer on their surface. This phenomenon can be
reproduced in vitro using simulated body fluid, a protein-free solution with ion concentrations
similar to those of human blood plasma.
b) Cell culture: Use osteoblast-like cells, to study the cell proliferation on the samples
c) To examine cytotoxicity and cell growth on the substrates, LDH and MTT assays were designed
for quantitative evaluation.
d) Histological analysis of air pouch tissue to determine any inflammatory response
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CHAPTER 2

Comparing the Release of Erythromycin and Vancomycin from Calcium Polyphosphate
Hydrogel Using Different Drug Loading Methods

Disclosure statement
Chapter 2 of this dissertation is derived from Chehreghanianzabi, Y., Barua, R., Shi, T., Yurgelevic,
S., Auner, G., Markel, D. C., & Ren, W. (2019). “Comparing the release of erythromycin and
vancomycin from calcium polyphosphate hydrogel using different drug loading methods”. The
following article and data are published in the Journal of Biomedical Materials Research Part B:
Applied Biomaterials and have been reused with permission from the publisher. All rights are
reserved.

2.1 Purpose and Hypothesis
The purpose of this aim is to acquire a comprehensive understanding regarding antibioticACPP hydrogel interaction as well as ACPP hydrogel properties upon antibiotic incorporation. In
this study two types of commonly used antibiotics namely EM and VCM for Osteomyelitis were
studied. The intention behind choosing EM and VCM was to demonstrate that hydrophobicity and
hydrophilicity of antibiotics can impact the elution. Preliminary experiments evaluate
microstructure, physicochemical properties, and activity of eluted antibiotics after release.
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2.2 Introduction
The bacterial infection is one of the most challenging topics in orthopedic tissue engineering.[9698] Osteomyelitis has been recognized as an inflammatory response that can actively transmit a
local infection to surrounding tissue and lead to bone loss.[99, 100] To address such a challenging
issue, localized antibiotics delivery from biocompatible bone cement material is one of the bestproposed solutions.[101] However, a desired and slow eluting antibiotic release method has not
been previously achieved.
Calcium phosphate cement (CPC) has been studied for more than 2 decades to address
common bone infections [102-105]. CPCs such as hydroxyapatite and tricalcium phosphate have
been widely studied as local antibiotic delivery carriers [30, 106-109]. However, the rate of
degradation and resorption of CPCs do not match well with the drug release and bone formation
rate. In addition to weak antibiotic binding to CPCs, hydroxyapatite restricts full antibiotic release
due to its low resorption rate [98, 110] as opposed to fast degrading tricalcium phosphate that
initiates early burst release of antibiotics [16, 111].
Currently, polymer additives are the approved materials to prolong drug liberation.[112116] These additives have emerged in bone tissue engineering to address CPC's limitations and to
strengthen drug release capability of CPCs.[116-118] However, due to the non-biodegradability
of some of these polymer additives, surgical removal is required. Thus, a polymeric biomaterial,
similar to bone material, with the ability to resorb in time is expected to resolve these limitations.
Calcium polyphosphate (CPP) is a biocompatible and biodegradable ceramic material. CPP
is osteoconductive and enables new bone formation on the surface both in vitro and in vivo. [71,
94, 119, 120] In 1977, Fukui et al. [121] at the first time reported the bone healing capacity of CPP
in a rat femur implantation model and noticed that CPP represents one of the desired bone graft
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substitutes because of its safety and high affinity to the bone. Current studies have shown that
CPP can be used as a ceramic-based local drug-eluting device [43, 58, 59, 94, 122]. Initial
observation on gelled CPP matrix showed the ability of linear CPP to delay antibiotic release using
repeated gelling protocol [43]. Dion et. al reported that VCM release was significantly reduced
during the first 2-4 h of elution, while it retained its bactericidal activity.[43] In a separate study,
they demonstrated by P-NMR and Raman Spectroscopy that antibiotic incorporation does not
transform the gelling-drying process.[58] However, polyphosphate chains presented in their
studies have not been fully hydrated, thus the antibiotic interaction with polyphosphate chains may
not be fully revealed in the gelled CPP, developed by Dion et. al. Recently, Song et. al. [72]
introduced a simple process to prepare CPP hydrogel that suggests a unique gel formation process
based on intermolecular ionic interaction and polyphosphate chain entanglement. The unique
interaction abilities of CPP hydrogel requires a deep understanding to reveal the antibiotics’
reaction mechanism. EM is known as a hydrophobic antibiotic with the ability to enhance bone
formation[123] and VCM is the most common hydrophilic antibiotic to treat osteomyelitis.[124127] In this study, the reaction mechanism of EM and VCM with fully hydrated polyphosphate
chains was investigated.
The goal of this study was to describe the drug delivery potential and properties of a novel
CPP hydrogel matrix made by exposing amorphous CPP to the large volume of water and applying
subsequent gel formation procedure. In this study, we demonstrate the effectiveness of fully
hydrated polyphosphate chains of CPP hydrogel on the interaction mechanism of antibiotic with
the hydrogel matrix.
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2.3 Materials and Methods
2.3.1 Synthesis of CPP powder and CPP hydrogel
Calcium phosphate monobasic monohydrate, (Ca[H2PO4]2 . H2O; Sigma-Aldrich, St. Louis,
MO) were calcined for 10 h at 500°C followed by melting for 1 h at 1200°C to produce an
amorphous glass and quenched at room temperature for cooling. The resulting material was
hammered to make small particles prior to grind in a planetary ball mill (Across International,
Berkeley, NJ). The resulting particles were sieved (Laboratory Test Sieves, Fisher Scientific,
Pittsburg, PA) continuously to segregate particles less than 75 µm. A Quanta FEG 450 scanning
electron microscope (FEI, Hillsboro, OR) and a Beckman Coulter particle size distribution
analyzer (LS 13 320 Series, Lakeview Parkway S Drive, Indianapolis, IN) show that particle sizes
obtained in this study are less than 10 µm (Figure 2.1 A-B). Prior to usage, CPP powders were
stored in a vacuum desiccator to avoid moisture absorption. For hydrogel preparation, CPP powder
was added to distilled water (0.1 g.ml-1), stirred for 90 min at 700 rpm at room temperature (25
°C) and suspended for 24 h until produced gel become precipitated and water phase becomes clear.
There is a phase separation between CPP gel and water after gelation.

2.3.2 Antibiotic loading
VCM and EM were selected as common clinically relevant treatments for methicillinresistant forms of Staphylococcus aureus (MRSA) infections. Noting that specific physiochemical
properties of antibiotics may influence their release profile accordingly. The influence of hydrated
polyphosphate chains on antibiotic binding mechanisms was studied by comparing two antibiotic
loading methods, namely “Powder_Mixture” and “Gel_Mixture” method. In Powder_Mixture
method antibiotics and CPP powders were mixed (1:10) (10 % (w/w)) by spatula for 10 min before
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gel preparation. In Gel_Mixture method, the antibiotic powder was added to the formed CPP
hydrogel (1:10) (10 % (w/w)) and mixed well to obtain a homogeneous gel as much as possible,
before testing.

2.3.3 Antibiotic release measurements
Gels prepared by both methods were submerged in 50 ml ultra-pure water and the volume
remained fixed throughout the experiment in static condition. To measure the released amount of
antibiotics, the antibiotic assay was run for 1ml of supernatant which was collected in 2, 24, and
48 h for both methods. The amount of VCM and EM released into the supernatant was measured
by absorption using an ultraviolet-visible spectrophotometer (BioTek Instruments, Inc., Winooski,
Vermont, USA). EM concentration was determined at 485 nm using regular 96-well plates, by
adding 0.1 ml of 3M sulfuric acid and 0.1 ml of supernatant to the plate and by heating it up to 50
°C for 30 min as well as by warming the plate reader up to the same degree in advance. This
reading method has been studied for EM by Arayne et. al. [128] and they found that 30 min of
warming up the plate reader can significantly enhance the absorbance at 485 nm.
VCM concentration was determined in a UV plate by a slightly different protocol. Briefly, 100 µl
of the sample solution was loaded in the UV plate and absorbance at 295 nm was measured. Ultrapure water was used as the assay solution. The experiment was repeated three times with duplicate
for each gel preparation method. Data were compiled for “VCM_Powder_Mixture” and
“VCM_Gel_Mixture”.
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Figure 2.1. ACPP Particle size analysis. (A) SEM analysis (1000 x magnification) demonstrated
that the particle sizes were less than 10 µm; (B) Particle size distribution test uses a dry powder
system and Fraunhofer optical method. The average number particle sizes are 0.68± 0.53 µm

2.3.4 Raman spectroscopy
An Invia Raman microscope (Renishaw, Gloucestershire, UK) with a 785 nm excitation
laser, and WiRE 3.3 software was used to measure the vibrational pattern of CPP hydrogel,
Gel_Mixture, and Powder_Mixture. A 50x N-plan Leica microscope objective with a numeric
aperture of 0.75 and a working distance of 0.75 mm was used for measurements. The laser power
was approximately 115 mW at the measurement site of 100% energy. Spectra were measured at
50% laser power for three accumulations of 10 s each over a spectral range of 200–1600 cm-1 with
spectral resolution varying from 0.87 to 1.11 cm-1. To eliminate background noises, the spectra
were preprocessed by applying an in-house developed LabVIEW procedure for background
subtraction and further normalizations.[129] Measurements were taken from each sample and
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averaged to achieve minor variations within the measurement system. The Raman spectra of CPP
hydrogel were measured immediately after antibiotic loading.

2.3.5 Rheological evaluation
Rheological experiment (ARG2, TA Instruments Inc., New Castle, DL) was performed to
measure the impact of antibiotics on the viscoelastic properties of CPP hydrogel. A standard 40
mm diameter parallel plate was used in this study. Gel_Mixture and CPP hydrogel were prepared
and submerged in water to stay fully hydrated. 1 mL of the fully hydrated gel was placed on Peltier
plate. An oscillatory stress sweep (from 0.001 to 1 Pa) at a fixed frequency (0.16 ºHz) was applied
to the sample. Frequency stress sweep and finally creep-recovery experiment with the fixed stress
and time values were performed. The viscoelastic measurements such as; storage modulus (G'),
loss modulus (G"), and complex viscosity |η*| as well as strain, were conducted for each sample.
For frequency sweep, all G', G", and |η*| were measured across a frequency range of 0.1-100 rad
s-1. The experiment was conducted at 25°C to evaluate dynamic viscosity of CPP hydrogel vs.
Gel_Mixture. Also, the manufacturer provided a solvent trap bar to be loaded at the first 300 s of
the experiment to avoid evaporation. Hydrogels loaded with antibiotics were prepared freshly prior
to the experiment.

2.4 Statistical analysis
The influence of the gelling process on the release rate of VCM and EM, throughout the
elution study, were analyzed by Paired Student T-test using excel where significant differences
were identified between antibiotic release from two treatment groups namely, Powder_Mixture
and Gel_Mixture. The release amount of EM and VCM from the powder_mixture method was
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significantly higher than release of the same antibiotic from gel_mixture method within the early
elution time points (p < 0.05).

2.5 Results
2.5.1 Antibiotic assay
The accumulated antibiotics release from Gel_Mixture and Powder_Mixture are shown in
Figure 2.2. As the data suggests, the antibiotic release was restricted more for the Gel_Mixture
method. The Gel_Mixture shows a significantly lower release of both EM and VCM [solid line]
as compared to Powder_Mixture up to 48 h of submerging in water [dashed line]. The 48 h
cumulative release of EM was ~7.5 % in Gel_Mixture, as compared to ~27.5 % in the
Powder_Mixture method. A similar pattern was observed for VCM. The 48-h cumulative release
of VCM was ~ 12.5 % in Gel_Mixture, as compared to ~ 22.5 % in Powder_Mixture method.
There is a release pattern difference between EM and VCM using both Gel_Mixture and
Powder_Mixture methods. Though the trend of release pattern of EM and VCM is similar using
the Gel_Mixture method, a higher release rate of EM was observed comparing to VCM using the
Powder_Mixture method. The drug release curves of EM and VCM was merged at ~27 h. The
release rate of VCM started to reduce post 27 h and remained at a lower rate of release for up to
48 h.
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Figure 2.2. Erythromycin (EM) and vancomycin (VCM) release (10 wt.%) from CPP hydrogel
prepared with both “Gel_Mixture” and “Powder_Mixture” methods for 2, 24, 48 hrs. EM and
VCM cumulative release concentration (%) in “Gel_Mixture” supernatant indicated by black and
red solid lines, respectively and EM and VCM cumulative release concentration (%) in
“Powder_Mixture” supernatant indicated by black and red dashed lines, respectively. The initial
concentrations of the antibiotics in the gel were 150 mg/ml, n=3 for each time point. Paired Student
T-test was performed and antibiotic release from powder_mixture was significantly different than
gel_mixture method for all the time points (p< 0.05).
However, antibiotic release in the Gel_Mixture method is 5% lower as compared to the
corresponding results from the Powder_Mixture method for the 2 h time point. This difference
increases for the 24 h and 48 h up to ~7% and ~20% for EM and ~7% and ~15% for VCM between
the two treatment groups, respectively. Thus, the rate of antibiotic release from the
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Powder_Mixture method is higher than their peers in the Gel_Mixture method, with respect to a
significant release rate increase of EM.
2.5.2 Raman Spectroscopy
Raman spectra of CPP hydrogel in isolation and in combination with antibiotics for both
Gel_Mixture and Powder_Mixture methods are shown in Figure 2.3.
Raman spectra of CPP hydrogel (Figure 2.3 Ab, Bb) contains three frequency regions to
provide distinctive features of the CPP structure. CPP spectra indicate linear P-O-P bonds at ~700
cm-1. The bands at ~1170 cm-1 and ~1290-1350 cm-1 represent symmetric and asymmetric
stretching of the PO2 bonds, respectively. These peaks correspond to our previous studies on
Raman spectral analysis.[72] The bands between 1170 cm-1 and ~1290-1350 cm-1 represent two
non-bridging oxygens (NBOs) bonded to phosphorus creating PO2 with symmetric and asymmetric
vibrations, respectively.[130]
Raman spectra of CPP hydrogel in isolation and in combination with EM for both
Gel_Mixture and Powder_Mixture methods are shown in Figure 2.3[A(a-d)]. EM has three
structural components: a lactone ring, a desosamine sugar, and a cladinose sugar. The reactive
groups of the desosamine sugar and the lactone ring mediate all the hydrogen-bond interactions of
EM. The dimethylamino group of the desosamine sugar can be found in both protonated (>96–
98%) and neutral (2–4%) forms. The protonated form of this group can easily interact, via an ionic
bond, in a pH-dependent manner with the oxygen.[131] The Raman spectrum of EM, as indicated
in Figure 2.3[Aa], contains lactone rings and two sugars: L-cladinose and D-desosamine. The
lactone is indicated around the 2800-3100 cm-1 region. Absorption at the range between 1650 cm1

and 1750 cm-1 corresponds to the C=O stretching vibrations of the hydrogen-bonded lactonic

group. The spectral region between 2800-3100 cm-1 may be attributed to the C-H stretching mode.
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Spectral vibration between 600- 900 cm-1 was observed due to the vibration of C-C, C-O and CO-C stretching of branched-chain monosaccharide, E-cladinose.[132]

Figure 2.3. Raman spectra of antibiotics isolation and combination with CPP hydrogel. CPP
hydrogel loaded with EM (10 wt.%) in both “Gel_Mixture” and “Powder_Mixture” methods. The
characteristics peaks of CPP are P-O-P, symmetric and asymmetric PO2 at ~700, 1170, and 1290
cm-1 bands at ~842, ~900 and ~1004 represents C-O-C deformation, C-C bond stretching and
breathing of aromatic rings, respectively (A), blank CPP hydrogel, and CPP hydrogel loaded with
VCM (10 wt.% ) in “Gel_Mixture” and “Powder_Mixture” methods (B), the powdered discs
loaded with EM for both methods were tested after elution for presence of any antibiotic peaks
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(C), the powdered discs loaded with VCM for both methods were tested after elution for presence
of any antibiotic peaks (D)
Incorporation of EM on CPP hydrogel represented as ‘EM_Gel_Mixture’ in Figure
2.3[Ad], exhibits reduced peak intensity at the 600- 3100 cm-1 range. This can be attributed to the
reduction of most of the bands and stretching obtained in EM spectra may indicate an interaction
between CPP and EM. In addition, the missing distinguishing peaks of CPP hydrogel and lactone
(2800-3100 cm-1) shift to a lower wavenumber is an indicator of CPP interaction with EM (Figure
2.3C). Generally, if the chemical bond length of molecules changes due to any internal or external
effects, then it may cause a shift in wavenumber. However, the shift directed to lower
wavenumbers may be attributed to the expansion of the C-H bond in the lactone group. The
decrease in particle size may cause peaks to shift to a lower wavenumber as well.[133] Further,
peaks between 600-1600 cm-1 shifted to a higher wavenumber. These peaks correspond to C-C, CO, and C-O-C stretching of branched-chain monosaccharide, E-cladinose. In our experimental
conditions, the temperature and particle size are considered constant during the measurements.
The peak shift to the higher wavenumber in this region is associated with axial compression of
bonds in these stretching groups.
Subsequently, in the Powder_Mixture method [Figure 2.3(Ac)], the Raman spectrum of
the EM-CPP combination indicates missing EM peaks, followed by a shift in CPP distinguishing
peaks to the higher wavenumber. Linear P-O-P bond, symmetric and asymmetric stretching of the
PO2 bond shifting to higher wavenumber is attributed to the contraction of polyphosphate chains
due to continued polymerization of CPP hydrogel which has been delayed due to the intervention
of EM in the hydrogel preparation process.
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Raman spectra of CPP hydrogel in isolation and in combination with VCM for both
Gel_Mixture and Powder_Mixture methods were shown in Figure 2.3(B). Raman spectra of
VCM, as indicated in Figure 2.3(B), exhibited peaks at ~830 cm-1, ~800 cm-1, ~1000 cm-1, ~1240
cm-1, ~1315 cm-1, 1475 cm-1, ~1615 cm-1, and ~1696 cm-1. Peaks at 800-1200 cm-1 can be assigned
to several stretching vibrations of the carbon chain. The bands at ~842 cm-1, ~900 cm-1, and ~1004
cm-1 represent C-O-C deformation, C-C bond stretching and breathing of aromatic rings,
respectively.[130] The peaks at ~1252 cm-1, ~1327 cm-1, ~1475 cm-1, ~1625 cm-1, and ~1696 cm1

represent characteristic of amide III (C-N stretching), deformation at CH2 and CH3 group, CH3

bending, carbonyl group (C=O stretching) of amide I and C=C stretching, respectively. Figure
2.3(B) indicates a broad peak at around ~2850 cm-1 to 3050 cm-1. This is indicative of CH3 and
aromatic CH2 groups at the VCM molecule.
Incorporation

of

VCM

on

CPP

hydrogel

(Gel_Mixture),

represented

as

‘VCM_Gel_Mixture’ in Figure 2.3(B), exhibits a reduction in peaks at the 800-1800 cm-1 range
which can be attributed to the reduction of most of the bands and stretching obtained in VCM
spectra. The low-intensity level of the spectrum is observed for an addition of only 10 wt. % VCM
in CPP. This can be an indicator of the interaction between CPP and VCM. CH2 and CH3 peaks of
VCM at ~2850 cm-1 to 3050 cm-1 shifted to the higher wavenumber which indicates a bond
shortening for C-H due to an interaction. The C-O-C deformation, C-C bond stretching and
breathing of aromatic rings, amide III (C-N stretching), deformation at CH2 and CH3 group, CH3
bending, carbonyl group (C=O stretching) of amide I and C=C stretching from 600-1700 cm-1
slightly shift to the higher wavenumber due to a shortening of bond length. Furthermore, VCM
incorporation on CPP hydrogel based on Powder_Mixture method indicates similar Raman
spectrum as compared with the spectrum of CPP, except a tangible shift to the lower wavenumber
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which is attributed to the expansion of polyphosphate chains due to continued polymerization of
CPP hydrogel which has been delayed due to the intervention of VCM in the hydrogel preparation
process (Figure 2.3D). The absence of characteristic peaks in 10 wt. % of VCM doped CPP
represents either weak spectra or missing of VCM observed in CPP hydrogel.
2.5.3 Viscoelastic properties
A standard Oscillatory series sweep test was performed to evaluate the viscoelastic
performance of CPP hydrogel and Gel_Mixture after antibiotic incorporation. In separate
measurements, the gel was subjected to an oscillatory stress sweep to find the linear viscoelastic
region (LVR), as shown in Figures 2.4(A) and Figure 2.5(A).
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Figure 2.4. Viscoelastic properties of EM loaded CPP hydrogel with “Gel_Mixture” method. An
oscillatory stress sweep test in an oscillatory range 0.001 to 1 rad/s at 25°C (A), an oscillatory
frequency sweep test with stress value from LVR at 25°C (B) Creep-recovery test under
nondestructive predetermined stress (MPa) and safe region of applied time. The recovery test was
designed after stress released for the same applied time as the creep test. Strain (%) was normalized
to be able to compare different conditions (C).
As shown in Figure 2.4, the viscoelastic property of CPP hydrogel was measured for assynthesized CPP and “EM_Gel_Mixture”. Storage modulus (G'), loss modulus (G″) and complex
viscosity (|*η|) were indicated by red, blue, and black colors, respectively. CPP hydrogel indicated
a viscous fluid property with a loss modulus (G″) higher than the storage modulus (G'). G' observed
around 1 Pa was slightly lower than G' (~ 2 Pa) reported elsewhere.[72] However, G″ observed
less than 7 Pa was almost seven times higher than as reported G″ (~1 Pa).[72] High G″ increases
G″/ G' ratio termed as tanδ which is a measure of internal friction of the material. The tanδ of CPP
obtained approximately more than an order of magnitude higher than as reported tanδ (7 vs.
0.5).[72] This increased value of tanδ was responsible for highly complex viscosity |*η| of CPP
hydrogel as high as 6 Pa.s, which were three times higher than the |*η|. From a physiochemical
standpoint, high internal friction represents a strong particle interaction.
Oscillatory stress sweep test performed on EM_Gel_Mixture are shown in Figure 2.4(A).
Values of G', G″, and |*η| are larger as compare to CPP hydrogel which indicates an elevated
viscosity because of EM incorporation. As shown in Figure 2.5(A), G' and G″ increased further
after VCM incorporation to CPP on VCM_Gel_Mixture, which is obvious due to the addition of
dissimilar particles with a complex chemical structure in the gel. However, the increase of G', G″,
and |*η| in EM_Gel_Mixture [Figure 2.4(A)] is much higher than the values that have been
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monitored for VCM loaded CPP [Figure 2.5(A)]. The difference in chemical structure between
VCM and EM may play a key role. Another reason is that EM is a hydrophobic drug that cannot
be dissolved in water. Complex viscosity (|*η|) of VCM loaded CPP increased as compared to the
complex viscosity of CPP hydrogel which indicates that the addition of VCM in CPP hydrogel
becomes slightly thicker. The viscosity of gel increased as the particle size decreases, as we
described before.[72] A large portion of CPP particles in the range between 1-5 µm, obtained from
particle size distribution analysis, may have an impact on the viscosity of CPP hydrogel. Higher
loss modulus (G”) than elastic modulus (G’) was observed for both cases, which confirms the
viscous material properties.
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Figure 2.5. Viscoelastic properties of VCM loaded CPP hydrogel with the “Gel_Mixture” method.
An oscillatory stress sweep test in an oscillatory range 0.001 to 1 rad/s at 25°C (A), an oscillatory
frequency sweep test with stress value from LVR at 25°C (B) Creep-recovery test under
nondestructive predetermined stress (MPa) and the safe region during the applied time. Recovery
tests were designed after stress released during the same applied time as the creep test. Strain (%)
was normalized to be able to compare different conditions (C)
To obtain information on the rubbery state of the hydrogel, it was subjected to an oscillatory
frequency sweep test shown in Figures 2.4(B) and Figure 2.5(B). The samples exhibit Maxwelltype behavior during the experimental frequency range (1- 100 rad/s), which is also reported, [72]
with a slight decrease in G' at 1 rad/s angular frequency. However, G″ showed a higher modulus
when parallel to G' which represents a high G″/ G' ratio indicating a high viscosity as compared to
results reported elsewhere.[72] The rheological behavior of CPP hydrogel indicates a viscous
polymeric hydrogel behavior as compared to typical polymeric hydrogel behavior reported.[72]
Therefore, results of oscillatory stress sweep [Figure 2.4(A), Figure 2.5(A)] and oscillatory
frequency sweep [Figure 2.4(B), Figure 2.5(B)] are comparable in the sense that increased value
of G″ as compared to G' was observed in both tests. However, increased values of G', G″, and |*η|
on VCM and EM loaded CPP during frequency the sweep test suggests that antibiotics increase
internal friction. This is elucidated by the fact that a significant increase of corresponding values
in EM loaded CPP, influenced by EM hydrophobicity, and avoids its full interaction with the
hydrogel matrix as opposed to the hydrophilic VCM case.
Finally, the creep-recovery of CPP hydrogel was tested and shown in Figures 2.4(C) and
2.5(C). A predetermined non-destructive oscillatory stress was applied in this test and the strain
values were measured over time. Recovery was tested after releasing the stress at the same time as
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a creep. The strain values were normalized and reported as strain (%). The creep-recovery profile
of CPP hydrogel, VCM, and EM loaded CPP overlapped. Particle size may play a crucial role in
overall viscosity results which can also explain the recovery result. Small (<75µm) particles
exhibit higher viscosity as compared to large (>75µm) particles because small particles have a
high surface area and exhibit high ionic interaction or chain entanglement due to chain
agglomeration of the particles with the high surface area. Particle size analysis [Figure 2.1]
indicates that synthesized particle sizes were less than 10 µm which may induce higher viscosity
as well as exhibit the slowest recovery. Gelation time after stirring the particles is also an important
factor to explain the high viscosity of the CPP hydrogels. CPP hydrogel prepared after seven days
of setting exhibited almost 75% recovery as compared to less than 10% recovery right after stirring
for 1.5 h.
Overall, the rheology results confirm that in the liquid phase, the active polyphosphate
chains of ACPP particles interact with each other, leading to the formation of a 3D network
structure via ionic bonds and/or chain entanglement. Upon VCM incorporation the viscosity and
rubbery properties of the CPP gel remain the same, however, the EM changes the CPP gel viscosity
and rubber-like structure based on its poor solubility.

2.6 Discussion
The purpose of this study was to determine the role of fully hydrated polyphosphate chains
on the interaction between the CPP matrix and antibiotics as well as the impact of antibiotics on
viscoelastic properties of the hydrogel. Regardless of antibiotic type, cumulative release (%) of
antibiotics into supernatant in the Gel_Mixture method demonstrated the lower tendency of
antibiotics to mix with water as opposed to the Powder_Mixture method as shown in Figure 2.2.
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This may have attributed to the formation of an early ionic bond between antibiotics and fully
formed and hydrated polyphosphate chains as well as physical wrapping of antibiotic molecules
by polyphosphate chains. Overall, the difference in release (%) of hydrophobic (EM) and
hydrophilic (VCM) antibiotics indicates that EM molecules tend to escape from water molecules,
therefore a less cumulative % of EM was observed in the supernatant as opposed to VCM. The
large complex viscosity of CPP gel loaded by EM also confirms the poor solubility of EM and
indicated coupling with hydrated polyphosphate chains as shown in Figure 2.4(A-C). Note that
unexpected EM release increments by approximately 5% as compared to VCM in Powder_Mixture
method indicated that the higher release of EM, which has smaller molecules as compare to VCM,
is based on matrix expansion as shown in Figure 2.2. Otherwise, the release of VCM is higher,
since VCM as a hydrophilic molecule can readily form a bond with water molecules taking into
account that VCM is highly soluble at a pH of 4.[134] This indicates that the elevation of pH
rapidly decreases the solubility of VCM to a minimum of approximately 15 mg/ml with a near
neutrality charge equal to zero . It is worth to mention that CPP gels exhibit low pH that constrains
its clinical application as local drug-eluting device alone. Therefore, we have developed an
injectable poly-dicalcium phosphate dihydrate (P-DCPD) forming cement by the reaction of acidic
CPP gel with alkali tetracalcium phosphate (TTCP)[135]. This neutral injectable P-DCPD cement
has been confirmed as an excellent drug-eluting bone graft substitutes for antibiotics and other
drugs (unpublished data).
In the Powder_Mixture method, most antibiotic molecules readily bond to water molecules
as soon as they contact with water molecules. Thereby, antibiotic interaction with polyphosphate
chains is restricted until the CPP gel is formed and the fully hydrated polyphosphate chains are
available for binding. Raman spectroscopic analysis similarly suggests that the antibiotic and the
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CPP hydrogel matrix do not initiate any interaction in the Powder_Mixture method. This is
indicated by the observation that antibiotics peaks appearing in the spectrum shown in Figure
2.4(Ac, Bc). Thus, the presence of the CPP peaks and the absence of antibiotics peaks in the Raman
spectrum of Powder_Mixture method indicates that antibiotics did not bind to the CPP matrix prior
to complete gel formation. The shift of CPP distinguished peaks to higher wavenumber must result
from continuous polymerization and contraction of CPP hydrogel which was delayed by
antibiotics intervention during the gelling process.
In contrast, the spectrum of Gel_Mixture indicates intensity reduction and the antibiotic
peaks appeared, which suggest antibiotics interaction with fully hydrated polyphosphate chains in
the formed hydrogel. In addition to the ionic bonds, fully hydrated polyphosphate chains create a
mesh-like structure that improves physical wrapping caused by polyphosphate chain
entanglement. Thereby, antibiotic loading effectively improved as opposed to the formed hydrogel
in the Powder_Mixture method. Nevertheless, the viscoelastic property measurement of CPP
hydrogel depicts the property alteration of the hydrogel where VCM shows lower complex
viscosity because of good solubility and interaction with CPP hydrogel than EM Figures 2.4,2.5
(A-C).

2.7 Conclusion and Future Work
The results of this study indicate that CPP hydrogel loaded by the clinically relevant
concentration of antibiotics retains EM and VCM (10 wt. %) within the matrix by 18% and 9%,
respectively, which are higher than antibiotic incorporation prior to hydrogel matrix formation.
The vibrational pattern of the Gel_Mixture method confirms that fully hydrated polyphosphate
chains in CPP hydrogel are a key element to initiate ionic interactions between antibiotics and the
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hydrogel matrix. It is evident immediately from emerging new peaks in the Raman spectrum of
Gel_Mixture method. In contrast to hydrophobic EM, the hydrophilic VCM can significantly
impact the viscoelastic properties of the hydrogel, suggesting that the molecular properties of
loaded antibiotics are another key element in hydrogel performance as a local antibiotic delivery
device. Loading antibiotics in fully formed CPP hydrogel enhances the antibiotic retention within
the matrix rather than adding antibiotics to the CPP powder prior to gelation.
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CHAPTER 3

Impacts of Compaction Methods on the Delivery Capabilities of Erythromycin and
Vancomycin from Calcium Polyphosphate Hydrogel Matrices

3.1 Purpose and Hypothesis
The purpose of this Chapter is to acquire a comprehensive understanding, regarding the
effect of molding methods on antibiotic release and activity. In this study two antibiotics namely,
EM and VCM were used. The long term release of antibiotics from ACPP discs made with two
different molding methods reveals the interaction properties of antibiotics with ACPP hydrogel
and is a good comparison for the interaction of hydrophobic and hydrophilic antibiotics during the
elution studies.

3.2 Introduction
It is known that more than two million bone graft procedures are being performed
worldwide each year with a high risk of infection [136]. Chronic osteomyelitis is one of the major
issues which is caused by a bacterial infection, post-surgery [137]. To prevent this prevalent
problem, besides systemic antibiotic administration, local antibiotic delivery is highly
recommended. To this goal, many bone cement materials loaded with a clinically relevant
concentration of antibiotics have been studied [138-141]. One of the most extensively studied
synthetic bone grafts is calcium phosphate cement (CPC) which has been widely used as injectable
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bone cement for bone defect fillings [16, 142-144]. Although CPCs are biocompatible and set in
room temperature, they do have some limitations, including weak mechanical strength [85, 145]
and inability to release the antibiotic in a concert with the treatment period [16, 110]. The weak
binding between loaded drugs and CPCs matrix surface is one of the main drawbacks. Thus a
polymeric bone cement material that can initiate a potent bond with antibiotics may be suitable.
Calcium polyphosphate (CPP) is composed of linear polyphosphate chains that possess
interesting mechanical and chemical properties in solution and in the solid-state and offers a wide
range of applications for tissue engineering and drug delivery devices [72]. Owing to the
importance of the subject, CPP’s capacity as an antibiotic delivery system has been addressed by
several studies, including investigation on VCM release behavior from amorphous CPP matrices
[43], the effect of processing on the structural characteristics of VCM-loaded amorphous CPP
matrices [58], effect of gelled calcium polyphosphate matrices on delayed antibiotic release [122],
compaction strategies for modifying the drug delivery capabilities of gelled calcium polyphosphate
matrices [59]. Dion et al. [43] claimed that a repeat gelling process on antibiotic-loaded CPP
significantly reduces the burst release of VCM during the initial 2–4 h of elution while extending
the effective antibiotic release period only by 80 h. The same group observed more homogenous
and prolonged drug release of VCM from compacted CPP discs as compared to their previous drug
release study. Before the last gelling step of repeated gelling protocol they compacted CPP powder
then exposed the discs to high humidity for the final step [59]. In repeated gelling procedures the
CPP and antibiotic molecules cannot make enough ionic bonds due to the lack of water molecule
availability, thus the release of antibiotic is with higher rate than when the complete hydrogel
formed.
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The CPP hydrogel has been developed in our research group with a unique technique and
in the presence of an excess volume of water [72]. One of the enhanced features of CPP hydrogel
is the bulk gelation and not the surface gelation only. Thus we recently have showed that antibiotic
loading efficiency increases through addition of antibiotic to fully formed CPP hydrogel rather
than powder to powder addition [146], and we will later show more precisely in this chapter that
water availability to CPP chains due to accelerating water molecule ingress and microstructural
transformation of CPP hydrogel, enhances antibiotic loading efficiency through the mechanisms
of intermolecular ionic interaction and entanglement of polyphosphate chains with antibiotic
molecules. As a result, we believe that CPP hydrogel can be a promising local antibiotic delivery
device for sustained antibiotics release with minimal impact on the material mechanical properties.
We also note that the CPP matrix formation can be a determining factor for sustained drug release
[146]. However intermolecular ionic interaction majorly effects antibiotic release, inconsistent
pore distribution throughout the condensed matrices in manually molded discs (M-discs) may
cause non-uniformity of the discs and thereby result in lack of mechanical strength of the matrix
and the burst release of the antibiotics. Nevertheless, discs made by compression molding method
(C-discs) which are expected to be more uniform and dense show prolong antibiotic release.
Petrone et. al. [59] also have demonstrated the improvement of antibiotic release by developing a
new compaction method in addition to the repeated gelling process previously mentioned in Dion
et. al study [43]. In this study, we are going to quantify the effect of the compaction strategies on
antibiotic release by performing release studies on discs that are prepared by compression molding
and manual molding methods.
In order to prove that water molecules, contribute majorly to the interaction processes of
antibiotic and CPP matrix, the effect of hydrophobic and hydrophilic antibiotics on the release
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efficiency has been tested. Based on this fact, the release of VCM as a hydrophilic antibiotic and
the EM as a hydrophobic antibiotic were investigated. The unique interaction abilities of CPP
hydrogel requires a deep understanding to reveal the antibiotics’ reaction mechanism. EM [147]
(EM, 733.937 g/mol) is known as a hydrophobic antibiotic with ability to enhance bone formation
[123] and VCM [148] (VCM, 1449.265 g/mol) is the most common hydrophilic antibiotic with
larger molecule to treat osteomyelitis, both were used in clinical practice.[124-127] In addition to
matrix preparation impact on drug release, in this study potential impacts of antibiotic size and
wettability on antibiotic release were investigated.

3.3 Materials and Methods
3.3.1 Synthesis of CPP powder and CPP hydrogel
CPP hydrogel was prepared as we reported elsewhere. [72] Briefly, Calcium phosphate
monobasic monohydrate, (Ca[H2PO4]2. H2O; Sigma-Aldrich, St. Louis, MO) was calcined for 10
hours at 500°C followed by melting for 1 hour at 1200°C to produce an amorphous glass and
quenched at room temperature for cooling. The resulting material was hammered to make small
particles prior to grind in a planetary ball mill (Across International, Berkeley, NJ). The resulting
particles were sieved (Laboratory Test Sieves, Fisher Scientific, Pittsburg, PA) continuously to
segregate particles less than 75 µm. Prior to usage, CPP powders were stored in a vacuum
desiccator to avoid moisture absorption. For hydrogel preparation, CPP powder was added to
distilled water (0.1 g.ml-1), stirred for 90 minutes at 700 rpm at room temperature (25 °C) and
suspended for 24 hours.

3.3.2 Drug loading
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EM and VCM [147] [148] (purchased from Sigma) were mixed with CPP hydrogel (1:10)
(10 weight % (w/w)) by a spatula, separately.

3.3.3 Disc compaction methods
EM and VCM were mixed with CPP hydrogel (1:10) (10 weight % (w/w)), separately. In
order to enhance handling properties of the mixture, the resulting pastes were placed in room
temperature for 24 hours to obtain semi-dried gel pre-molding.
To understand the role of matrix structure on antibiotic elution, for each antibiotic two types of
elution matrices were designed and the discs’ properties and a schematic of disc preparation
procedure were summarized in Table 3.1 and Figure 3.1, respectively.
Manual method
Like the first type, Semi-dried gel mixtures were weighted and separated into four equal
portions, then manually filled in disc-shaped plastic molds (Figure 3.1). The filled material was
placed in room temperature for 1 week to dry.
Compression method
The compressed discs (C-discs) were prepared via a mechanical compressor (CARVER,
Wabash, IN. USA) with a mean pressure of 3000 psi (Figure 3.1). All the samples from both
groups were placed at room temperature for 1 week to stabilize their weights. The amount of water
added to each disc was calculated based on the weight of each disc.
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Figure 3.1. Schematic of molding methods used in this study; compressed and manual.

3.3.4 Structural evaluation of discs’ pre-elution
Micro-computed tomography
A structural difference between the two types of discs was evaluated by microcomputed
tomography (µ-CT) (vivaCT 40, Scanco Medical AG, Brutti- sellen, Switzerland) analysis. The
CT scan was performed at an energy of 70 kVp and an intensity of 114 µA. The slice thickness
was set at 10.5 µm and data collected with an integration time of 320 ms. Following reconstruction,
the specimen volume of interest was selected and pore structures analyzed using the built-in
software. Briefly, a binary threshold was applied to separate sample material from pores, and
image processing techniques used to calculate the diameter of pores in three dimensions. The
results were summarized in Table 3.2.
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Scanning electron microscopy
Discs were fixed on a strip of carbon tape (Ted Pella, Redding, CA). A Quanta FEG 450
scanning electron microscope (FEI, Hillsboro, OR) was used to collect images of each sample at
magnifications of both 50x and 1000x (Figure 3.2). For all samples, the power was set to 10 kV
and the spot size was set at 4 for imaging. All samples were imaged and analyzed in a low-vacuum
setting of approximately 0.45 torr with no coating.

3.3.5 Antibiotics release and bactericidal activity assay
Upon curing, antibiotic-loaded CPP hydrogel discs were submerged into the 1:10 ratio (1
g disc submerged in 10 ml ultra-pure water) ultra-pure water in sealed containers and maintained
in 37 °C. Supernatants were collected completely at predetermined time points and replaced with
the same amount of fresh media. At the completion of the release study, the discs were dried and
weighted to calculate the total mass loss. weight before soaking (W1) and weight after soaking
(W2), the weight loss: ΔW = (W1- W2)/ W1. A summary of weight loss values is shown in Table
3.3.
The concentrations of EM and/or VCM released from discs were measured via a microplate
reader (Synergy HT, BioTek Instruments, Inc., Winooski, Vermont, USA) at the absorbance
wavelength of 486 nm and 295 nm, respectively and converted to a known concentration of each
antibiotics using internal standard curve. The antibiotic cumulative concentration (%) measured
by the microplate reader was calculated based on the concentration of loaded antibiotics of each
disc. Due to UV properties of VCM, the elution from VCM-loaded discs was transferred into a
UV transparent 96 well plate for microplate reader measurements.
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A modified minimum inhibitory concentration (MIC) assay was developed to measure the
antibacterial activity of eluted EM and VCM in pre-determined time points. The MIC was
determined by the lowest concentration that inhibited the growth of bacterium as characterized by
a lack of turbidity and lower OD readings. Briefly, a Mueller–Hinton broth inoculated with S.
aureus spores (CDC 587, #49230 American Type Culture Collection, Manassas, VA) was cultured
at 37°C until an absorbance reading of 0.08–0.1 was attained at 625 nm, corresponding to roughly
1 × 105 CFU/mL. Then 100 μL of VCM eluent from M and C discs (VCM-M and VCM-C) and
100 μL of EM eluent from M and C discs (EM-M and EM-C) were collected at various time points
and added into 900 μL of the bacterial broth. All the bacterial samples incubated at 37°C for 22 h,
followed by OD measurement at 625 nm. Bacterial culture in Mueller–Hinton broth without
antibiotics considered a positive control. Antibacterial activity assays were conducted in duplicate
for both the blank and testing samples. The MIC100 was determined 2 mg/L for both EM and VCM.
In parallel, the pH of the elution medium was measured at each time point and summarized in
Figure 3.6.

3.3.6 Structural analysis of remnants post-elution
Raman spectroscopy analysis
The composition of CPP discs residues (after the drug release experiments) was evaluated
by Raman spectroscopy to qualitatively assess any structural changes that might have occurred
during aging. To this goal, the residuals of M and C discs were centrifuged, and the supernatant
was removed and the remnants were dried after collecting the last time point. Then dried samples
were ground to obtain a fine powder for further studies.
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An In Invia Raman microscope (Renishaw, Gloucestershire, UK) with a 785 nm excitation
laser, and WiRE 3.3 software was used to measure the vibrational pattern of the remnant of postelution matrices. A 50x N-plan Leica microscope objective with a numeric aperture of 0.75 and a
working distance of 0.75 mm was used for measurements. The laser power was approximately 115
mW at the measurement site of 100% energy. Spectra were measured at 50% laser power for three
accumulations of 10 s each over a spectral range of 200–1600 cm-1 with spectral resolution varying
from 0.87 to 1.11 cm-1. To eliminate extra noises, spectra were preprocessed by applying an inhouse developed LabVIEW procedure for background subtraction and further normalizations
[129]. Measurements were taken from each sample and averaged to achieve minor variations
within the measurement system. The Raman spectra of powder samples were measured for each
group.

3.3.7 Eluent pH
Eluent pH of antibiotic-loaded ACPP discs immersed in distilled water was measured via
a Fisher Scientific accumet AE150 pH meter (Hampton, NH) with accumet 13-620-AE6 electrode.
The pH values of all discs were measured for all time points and up to two weeks were summarized
in Figure 3.6.

3.4 Statistical analysis
The influence of the compacting method on the release rate of VCM and EM, throughout
the elution study, were analyzed by Student T-test using excel where significant differences were
identified between 2 treatment groups namely, manual and machine compressed (p<<0.05). Also,
the influence of antibiotic type on the release amount within each compaction method was
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analyzed by the same test, where no significant difference was identified (p>0.05). A significant
difference was detected (p<<0.05) in the antibacterial activity of released VCM between M and C
discs.
3.5 Results
3.5.1 Structural evaluation of discs’ pre-elution
The influence of the compaction method on CPP matrix microstructure was evaluated by
Scanning electron microscopy (SEM) and Microcomputed tomography (µ-CT).

Table 3.1. Physical properties of compressed and manual samples used in elution study
Properties

Manual

Compressed

Blank

VCM

EM

Blank

VCM

EM

*P value

Thickness

0.422 ± 0.025

0.492 ± 0.053

0.522± 0.04

0.806 ± 0.002

0.880 ± 0.062

0.904 ± 0.036

< 0.05

Diameter

1.386 ± 0.004

1.366 ± 0.026

1.377 ± 0.011

1.308 ± 0.002

1.292 ± 0.005

1.306 ± 0.004

> 0.05

Weight. (g)

1.036 ± 0.101

1.150 ± 0.145

1.177 ± 0.104

2.057 ± 0.11

1.992 ± 0.181

2.092 ± 0.121

< 0.05

Micro-computed tomography
The values of structural properties reported in Table 3.2 showing that M discs have higher
porosity and the mean pore size is larger than C discs and statistically, there is a significant
difference in porosity (%) of these two groups (n = 4, p < 0.05). However, there is no significant
difference in the mean pore size of these 2 groups (n = 4, p<0.05).
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Table 3.2. Structural Properties of Discs by µ-CT
Group

Porosity (%)

Mean Pore Size (mm)

Manual (M)

9.313±3.351

0.235±0.219

Compressed (C)

4.837±2.197

0.085±0.033

*P value

<0.05

<0.05

Scanning electron microscopy
SEM observation revealed micro-cracks and surface roughness on the surface of M-discs
and C-discs (Figure 3.2). However, the micro-cracks observed on both discs, those are slightly
deeper in M-discs, so the M-discs are structurally more fragile as compared to C-discs. Material
agglomerations were detected on the surface of the M-discs as they can be found as white spots in
Figure 3.2.

Figure 3.2. Surface morphology of antibiotic release samples prior to release for M (A) and C (B)
discs. Magnification is 100x.
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3.5.2 Antibiotic release and bactericidal activity assay
The cumulative release (%) of VCM and EM from M and C discs (VCM-M, VCM-C, EM-M,
and EM-C) with the physical properties given in Table 3.2 were measured throughout the
predetermined time points and the results are shown in Figure 3.3.
The significant burst release was indicated in M discs for both EM (64.9 ± 11.5 %) and VCM
(66.5 ± 8.5 %) within 2 weeks. The higher burst release was observed at early time points for the
M discs. While the measured release of VCM up to 2 months for C discs showed no burst release
in EM and VCM loaded discs. Also, the sustained release was observed in C-discs for EM (49.3 ±
2.9 %) within 4 weeks and VCM (55.5 ± 11.9 %) within 2 months as compared to M-discs.
Generally, C-discs show higher sustained release as compared to M-discs which have earlier
and shorter sustained release. In addition, a more sustained release of VCM starting from 72 hours
up to 9 weeks was observed as compared to EM in C-discs starting from 8 hours to 3 weeks.
Comparing the burst release of EM and VCM over the course of 48 h (Figure 3.3 (C,D)), realized
that manual samples are shown in Figure 3.3 C, immediately release almost 50% of antibiotics in
24 h and 65% in 48 h and there is no significant difference between the release of EM and VCM
for manual samples. In Figure 3.3 D, antibiotics’ burst release from C-discs reduced significantly
due to compaction method. The EM and VCM release is almost the same at 24 h of release and it
is around 1.5 %, however the EM release leveled up for the 48 h of release to ~4%.
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Figure 3.3. The release pattern of vancomycin and erythromycin from manually (A) and
mechanically compressed discs (B), the burst release comparison for manual (C), and compressed
samples (D) in seven time points over the course of 48 h. Statistical significant differences
indicated by (*) (n=4, p < 0.05).

Released VCM is stable and retains its antibacterial activities, as shown in Figure 3.4. In
agreement with the VCM release profile, C-discs has a slower and more sustainable release all
above MIC concentration, thereby, a sustained and longer above MIC bacterial inhibition was
observed. Released VCM from both C-discs and M-discs within the first week significantly
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inhibited bacterial growth. However, bacterial growth inhibition of M discs was reduced (49.9 ±
53.4 %), whereas C discs retain their strong bacterial growth inhibition (99.6 ± 0.6 %) up to 2
months (p = 0.005).
The reported minimal inhibitory concentration (MIC) for EM and VCM against S. aureus
(ATCC) is 2.0 μg/ml, demonstrating that the antibiotic concentrations released from these discs
construct the volume were always above the MIC.

Figure 3.4. Bacterial growth inhibition percentage was obtained by normalizing bacterial growth
inhibition without the presence of any release media. Statistical significant differences indicated
by (*) (n=4, p < 0.05). Bacterial growth inhibition by VCM measured up to 2m (A), and for EM
measured up to 6 h.

3.5.3 Structural analysis of remnants post-elution
Raman spectroscopy analysis
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Pre-release and post-release Raman spectra of CPP discs in isolation and in combination
with antibiotics for both manual and compressed discs are shown in Figure 3.5.
Generally, the Raman spectra of CPP disc pre-release, contains three frequency regions to
provide distinctive features of the CPP structure. CPP spectra indicate linear P-O-P bonds at ~690
cm-1. The bands at ~1170 cm-1 and 1340 cm-1 represent symmetric and asymmetric stretching of
the PO2 bonds, respectively. The bands between 1170 cm-1 and 1340 cm-1 represent two nonbridging oxygens (NBOs) bonded to phosphorus creating PO2 with symmetric and asymmetric
vibrations, respectively.
A significant post-release change of spectra was observed throughout the samples. As it
has shown in Figure 3.5, the post-release Raman spectrum of VCM loaded samples indicates
that VCM remained within the matrix by appearing the characteristic peaks of VCM. In contrast
to EM loaded samples a few EM characteristic peaks were detected at ~400, ~600, and ~1100 and
the strongest characteristic peaks belong to CPP gel.

Figure 3.5. Raman spectra of VCM, VCM-C discs (A), EM, EM-C discs (B), pre-release and postrelease is showing VCM remnants within matrix after ~3 months of release
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As indicated in Table 3.3, the remnant of samples was used to determine the weight loss % at
the completion of the release study. The C-discs retained higher percentage of their original mass
and M-discs lost more weight upon washout. Blank samples lost less weight significantly in
compare with antibiotic-loaded discs (n = 4, p < 0.05). The weight loss of EM loaded discs, also
showed significant difference between C and M discs (n = 4, p < 0.05). However, the weight loss
of VCM loaded discs is not significantly different within C and M discs, and the statement is true
for EM as well (Table 3.3).

Table 3.3. Post-elution weight loss of discs
Properties

Manual

Compressed

Weight (g)

1.036 ± 0.101

1.150 ± 0.145

1.177 ± 0.104

2.057 ± 0.11

1.992 ± 0.181

2.092 ± 0.121

Weight. loss (%)

95.174 ± 0.02

96.051 ± 2.329

95.88 ± 0.258

88.333 ± 0.03

94.285 ± 1.032

91.52 ± 1.529

3.5.4 Eluent pH
Eluent pH of ACPP discs in isolation and combination of antibiotics for both compaction
methods is summarized in Figure 3.6. Overall compressed samples regardless of antibiotic types
show a slow rise in pH, and EM loaded samples experiencing higher pH within first two weeks in
comparison with blank and VCM loaded samples.
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Figure 3.6. Monitored pH of elution within 2 weeks. the pH of manual discs is not significantly
different within the manual samples (p > 0.05), while the pH of the compressed discs is
significantly different between blank , VCM , and EM loaded discs. (p < 0.05)

3.6 Discussion
Many factors are involved to obtain a desired antibiotic delivery device which controls
antibiotic release in a sustainable manner and in harmony with the material degradation. Here we
proposed a delivery system which is capable of releasing an effective dose of antibiotic that
remains above the MIC throughout the release period. Mainly, we explain how ionic interaction
and compaction methods can improve the release of antibiotic. Principally, a challenging part of
any localized drug delivery devices is the burst release of therapeutic within the initial hours of
implantation. Antibiotic release from CPP was first studied by Dion et.al.[58] where the gelled
CPP was prepared under humidified condition. Their study shows a high initial release of VCM in
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0.5 h , with reaching a cumulative release of 72 % of the calculated amount of incorporated VCM.
It is worth to mention that the cumulative release of VCM reaches above 50 % in less than 50 h.
In our study, the CPP hydrogel as an antibiotic carrier was studied to compare two antibiotics and
two compaction methods. Samples were divided into M-discs and C-discs. The larger pores and
higher porosity % of M-discs rationalizing the higher release of antibiotics (Table 3.3). The
surface morphology of discs was shown by SEM images (Figure 3.2) and clearly indicating the
deeper fractures over the surface of the M-discs in comparison with C-discs.
The total cumulative release of antibiotics is reaching ~65 % and ~55 % of the calculated
amount of incorporated antibiotics in M-discs and C-discs, respectively. In the CPP hydrogel
formation, there is a strong ionic association between calcium (Ca2+) or other multivalent cations
and the linear polyphosphate ions in water, which can result in the formation of a hydrogel. The
cations which are capable of bridging between linear polyphosphate chains, effectively create a
polymer network, leading to hydrogel formation. Positively charged molecules such as VCM
would show an affinity for the ionic bond.
Raman spectroscopy on post-release samples indicates that some EM still remain within
the matrix since some characteristic peaks of EM appear in the post-release spectra (Figure 3.5A).
Similarly, the VCM group post-release still contains characteristic peaks of VCM which is
indicating that a strong ionic bond holds VCM and CPP matrix together even after 2 months of
release (Figure 3.5B).
In C-discs the VCM and EM release reach 4% and 15% in 5 d, respectively, that shows the CPP
matrix made by compression sustained the release of antibiotics.
However, the released amount of VCM from C-discs was very low at the initial time points,
it’s antibacterial activity remained above MIC level. EM’s sensitivity to low pH [149, 150]
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compromised its activity and the activity reduction was impacted by the cleavage of EM molecule
in an acidic environment. Thus the low antibacterial activity of EM was not reported throughout
the entire release period and Figure 3.4B indicates the prohibition for 1 w. While reports show
that VCM has higher antibacterial activity in lower pH [151], thus the activity of VCM retained
higher than 80% in C-discs.
Comparing the pH of elution obtained from C-discs and M-discs, the pH is significantly
(p<<0.05) lower in blk-c vs blk-m samples due to more homogeneity of the samples. The pH
during the release is not too significant (p<0.05) between different time points of VCM loaded,
and not significant between EM loaded samples.
Antibiotic loaded samples generally have higher pH indicating that the interaction of antibiotics
with PP chains may accelerate the dissolution process of CPP and the released material raises the
pH faster. Furthermore, pH significantly changed between blank, VCM and EM loaded samples
in C-discs, while within manual samples pH remains constant.
In VCM loaded C-discs, pH value is significantly lower than VCM loaded M-discs. This
may be due to the strong ionic bond that VCM makes with the CPP matrix and provides a more
homogenous environment in comparison with M-disc. Indicating that hydrophilic VCM molecules
bond well with hydrated PP chains in a way that intervenes less to the matrix structure.
In fact, the manufacturing process has a significant effect on the dissolution and
degradation process of CPP discs and as result on pH. As it has been shown in Figure 3.6, in
compressed discs the pH raises slowly in comparison with less dense samples (M-disc). Since
compressive manufacturing only increased the matrix density due to compression pressure but not
the structure at ionic level, so the slight pH increase might be due to the slow degradation of matrix
lead to delayed acidic phosphate release.
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3.7 Conclusion and Future Work
VCM ionic bond to the CPP matrix provides a more sustained release. Compressed samples
as a denser disc may retain antibiotics more effectively within the matrix. Imbedding EM within
the acidic CPP matrix compromised EM biological efficacy which may be addressed by elevating
the pH of elution medium or by modifying EM to be more resistant therapeutic in further studies.
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CHAPTER 4

Antibacterial Activity of Polymeric Dicalcium Phosphate Dihydrate (P-DCPD) Loaded
with Antibiotics

4.1 Purpose and Hypothesis
In this aim, I perform a very well-known bacterial agar plate for determining bacterial
inhibition zone. The releasing antibiotic from P-DCPD discs, prepared with different loading
methods, inhibits the bacteria growth in the agar plate in a ring shape. I measure the inhibition
zone and based on the inhibition area, I explain the release of antibiotics and relate it to previous
release data from ACPP hydrogel (Chapter 3). The experiment is a complimentary set of
experiment to confirm polymeric cement capability to perform as local antibiotic delivery matrix
by retaining antibiotics antibacterial activity. In Chapter 3, the pH of ACPP impacts the
antibacterial activity of EM completely, and VCM partially. As shown in Figure 4.1 the pH of PDCPD stays in neutral pH and differs significantly than the pH of ACPP for the same exposure
time.
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Figure 4.1. pH values for P-DCPD and ACPP elution medium (1 day, 2 days, 3 days, and
4 days).
The pH of ACPP hydrogel is very low and the acidic environment damages EM structure,
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thus reduces EM’s activity throughout the release period. In contrast, VCM is more resistance to
an acidic environment and retains its activity even in a highly acidic environment.

4.2 Introduction
Owing to ACPP hydrogel's unique properties, P-DCPD with a novel formula makes a
polymeric DCPD cement which forms completely different than monomeric classical CPCs.
Previously many materialistic aspects of P-DCPD cement were analyzed in our research group
[135]. As means to address antibiotic sensitivity and susceptibility as compared to ACPP, it is
necessary to know that P-DCPD cement made by polymeric ACPP hydrogel as the acidic calcium
source suggests a completely different setting reaction as compared to classical CPCs setting
formula. The reaction of monomeric acidic calcium source with alkali calcium source provides a
polymeric bone cement that not only has to be mechanically stable and biocompatible, also the
therapeutics has to be delivered effectively. Previously, other polymeric bone cement materials
such as poly (methyl methacrylate) (PMMA) were mixed with ACPP hydrogel and the release of
VCM and tobramycin were significantly improved in a sense that the burst release reduced, with
a minor reduction of antibiotics effect [152]. ACPP shows promising characteristics as a local
antibiotic delivery carrier with a prolonged release and high activity of VCM. Although roughly
the same release of antibiotics is expected from P-DCPD due to presence of fully hydrated
polyphosphate chains, EM and VCM activity might be different in P-DCPD since the pH of PDCPD is very neutral. This motivates me to explore the bacterial inhibition of P-DCPD cement
discs loaded with EM and VCM.
One of the common approaches to test antibiotics sensitivity is via the disc-agar diffusion
method. The Kirby-Bauer method is usually used for antimicrobial susceptibility testing. NCCLS
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is an international organization composed of medical professionals who promote accurate
antimicrobial susceptibility testing (AST). The Kirby-Bauer method is approved by NCCLS.

4.3 Materials and Methods
4.3.1 Discs Materials, Manufacturing, and Antibiotics Loading
I prepared a thin layer P-DCPD cement disc loaded by 10 wt. % of antibiotics. P-DCPD
cement discs were prepared by mixing CPP hydrogel and tetra calcium phosphate (TTCP) and
sodium citrate with a weight ratio of 1:0.87:0.15, w/w/w at room temperature. This mixture was
molded in thin disc shape molds.
To test the idea that the presence of hydrated polyphosphate chains improves antibiotic
interaction with the matrix, I decided to measure the inhibition zone for two antibiotic loading
methods. In the first method, I added VCM and EM each in 10 wt. % of total cement weight to
ACPP hydrogel and mixed it with hydrogel. Subsequently, to form the cement the TTCP and
sodium citrate powder was added to the mixture of antibiotics and ACPP hydrogel. In the second
method the antibiotic powder in 10 wt. % of total cement weight was added to the mixture of TTCP
and sodium citrate powder and afterward the powder mixture was added to ACPP hydrogel to form
the cement. The whole procedure was performed under sterile conditions. The average weight of
the discs was ~166.25 ± 0.02 mg and in this way we can estimate that ~16.62 ± 0.001 mg of each
disc was loaded by antibiotic. By calculating the volume of each disc and wt.% of drug, ~ 0.6 ±
0.003 g/ml of antibiotic is loaded in each disc.
The summary of the type of discs was indicated below:
(a) P-DCPDEM (hydrogel mix): P-DCPD cement disc, loaded with EM in a way that EM was
mixed with the ACPP hydrogel phase.

65

(b) P-DCPDVCM (hydrogel mix): P-DCPD cement disc, loaded with VCM in a way that VCM
was mixed with ACPP hydrogel phase.
(c) P-DCPDEM (powder mix): P-DCPD cement disc, loaded with EM in a way that EM was mixed
with TTCP and sodium citrate powder.
(d) P-DCPDVCM (powder mix): P-DCPD cement disc, loaded with VCM in a way that VCM was
mixed with TTCP and sodium citrate powder.

4.3.2 Antibacterial Activity of P-DCPD Disc-Agar Diffusion Method
The assessment of the antibacterial activities was firstly conducted towards the S. aureus because it
appears to be most commonly found in orthopedic implant infections.
Briefly, a Mueller–Hinton broth inoculated with S. aureus spores (CDC 587, #49230 American
Type Culture Collection, Manassas, VA) was cultured at 37°C until an absorbance reading of 0.124
was attained at 625 nm, corresponding to roughly 1 × 105 CFU/mL. Then 0.5 ml of bacteria was
dispensed onto the surface of the agar plate (Figure 4.2 a). Each disc was pressed down to ensure
complete contact with the agar surface (Figure 4.2 b). Discs were distributed evenly so that they are
no closer than 24 mm from the center to center. No more than 12 discs were placed on one 150 mm
plate or more than 5 discs on a 100 mm plate. The plates were inverted and placed in an incubator set
to 37C within 15 minutes after the discs were applied (Figure 4.2 c).
After 22 hours of incubation, each plate was examined. Based on satisfactory experimental
procedure, the resulting zone of inhibition is uniformly circular and there is a confluent lawn of
growth. In detail, the S. aureus was used for the test, which was among the most formidable pathogens
because of their ability to cause serious bone infections after implantation. The concentrations of
bacterial inoculation solution applied in different test series were standardized by UV. After 22 h
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incubation at 37 °C, the inhibition zone around the disc samples was defined and measured as the
diameter of the inhibition zone excluding the samples. The antibacterial effect was assessed by the
radius of the inhibition zone.
a

b

c

Figure 4.2. Disc-agar diffusion method. Dispensing 0.5 ml of the bacteria on the agar plate and try to
be absorbed by the agar gel properly (a), macroscopic appearances of P-DCPD scaffolds which were
press down into the agar gel (b), and finally flip over the agar plate and place the plate into an incubator
with 37 °C for 22 h (c)

4.4 Data Analysis
All the experiments were repeated 3 times for each group for different time intervals and
were summarized. The diameter of inhibition zones and the optical density of antibiotics within
each plate were expressed as mean ± SD. ANOVA was used as statistical analysis.

4.5 Results
4.5.1 Bactericidal Activity
Antibacterial activity of antibiotic-loaded P-DCPD discs with different loading methods
was assessed by diffusion agar plate method. As it has shown in Figure 4.3 inhibition zones are
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clearly determined by creating a ring around the discs. As expected the diameter of inhibition zone
around the blank P-DCPD disc is very tiny and is 1.5 ± 0.001 cm. The diameter of EM loaded
discs is significantly larger than vancomycin loaded discs (Figure 4.3 a, c), but there is no
significant difference between loading types for both VCM and EM loaded discs.

d
Blank
Disc

c

b
a

Inhibition Zone

Figure 4.3. Growth of S. aureus on the agar plate. Scaffolds were incubated on the sterilized agar
plate for 24 h. (a) P-DCPDEM (hydrogel mix) (b) P-DCPDVCM (hydrogel mix), (c) P-DCPDEM
(powder mix), (d) P-DCPDVCM (powder mix)

The quantitative analysis of inhibition zones was assessed in Figure 4.4. The diameter of
the inhibition zone was measured by ruler from 3 different angles then the average was taken
between different measurements.
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Figure 4.4. Quantitative analysis of the inhibition zone diameter for each disc. (X-Gel: x was
mixed with gel phase, CPP gel, of P-DCPD bone cement, X-Powder: x was mixed with powder
phase, TTCP, and sodium citrate, of P-DCPD bone cement). * indicates that the difference was
significant where the p < 0.05.

4.6 Discussion
EM and VCM release from CPP hydrogel have been studied before and we described the results
in Chapter 3. As it was shown, EM releases faster than VCM and the large amount of EM could
kill ~90% of bacteria in the first week of release. Due to antibiotic depletion from CPP discs and
acidic nature of CPP hydrogel the activity of EM decayed. In the agar plate experiment the EM
inhibition zone appeared to be larger for 22 h of exposure to the same bacteria. Current results are
in correlation with the previous antibiotic release results. The smaller inhibition diameter of VCM
loaded discs, unlike EM loaded discs, is indicating the strong bond of antibiotics to the matrix.
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4.7 Conclusion and Future Work
In conclusion, although results obtained from antibiotics release from ACPP hydrogel,
demonstrated the higher activity of VCM in comparison with EM, here we observed that P-DCPD
loaded antibiotic with neutral pH and within the shorter time (22 h) preserves antibiotic activity.
EM fast and large volume release was observed here again and it is evident from the
significantly larger inhibition zone than VCM one.
VCM makes a strong bond to the CPP matrix and the antibiotic loading approach doesn’t
have significant effect on the antibiotic release and activity at all.
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CHAPTER 5

Physiochemical Comparison of DCPD and P-DCPD

5.1 Purpose and Hypothesis
This aim was developed to study physiochemical differences between the structure of
DCPD and P-DCPD particles upon incubation at different time intervals. P-DCPD prepared by
ACPP hydrogel owns polymeric properties with completely different properties that DCPD which
made from monomeric calcium phosphate material. In this study, we utilized various techniques
to study fine size particles of DCPD and PDCPD cement, treated under humidified condition (37
°C) for 1, 4, 7, and 14 days.
Some of the key differences between P-DCPD and DCPD have been investigated previously.
Based on this study, the setting reaction mechanism of P-DCPD is due to the intermolecular
interaction between CPP gel and TTCP, which was supported by XRD, AFM, Raman spectra
analysis and SEM. The setting mechanism of P-DCPD is completely different from the classical
calcium phosphate cement (CPC) that achieves crystallization by monophosphates reaction. PDCPD represents a new type of poly-CPCs with significant advantages, including strong
mechanical strength, excellent cohesion and easy of handling. We are going to investigate more
deeply the differences between P-DCPD and DCPD using various techniques. In this study,
particle differentiation based on surface morphology was investigated by SEM and Ca/P ratiobased differentiation of particles has been analyzed by EDS. To determine the dynamic change of
bonding (vibrational) mechanism through incubation times, Raman spectroscopy was utilized.
Phase changes and molecular identification were investigated through XRD. Measurement of net
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charge of particles in H2O immersion has been done using Zeta Potential. Surface contact angle
additional to surface hydrophobicity can reveal the relative absorbance rate on the surface of the
cement which is another key factor to unravel information on physiochemical differences between
P-DCPD and DCPD.

5.2 Introduction
P-DCPD is a new formula to make polymeric DCPD cement in which its physiochemical
behavior is completely different than classical CPCs. In our research group, a study was conducted
to compare injectability, cohesiveness, mechanical properties as well as setting mechanism of this
newly developed cement.
Based on the reported results, P-DCPD has similar handling properties of classical CPCs.
However, P-DCPD cement possesses stronger mechanical properties and excellent cohesion upon
wash out. CPC can be divided into HA and DCPD cement. Dicalcium phosphate dihydrate
(DCPD), has calcium to phosphate Ca:P ratio of 1 and hence calcium phosphates with Ca:P ratio
higher than 1 can be utilized to make brushes. TCP is the most common basic calcium source in
brushite cement (Ca/P ratio of 1.5).
It is known from the literature [135] that two processes involve in P-DCPD formation; first,
dissolution–precipitation mechanism and second, by deprotonating of the phosphonate followed
by the formation of intra- or inter-chained bonding of Ca2+ from TTCP with phosphonate ions
from CPP. The reaction of an acidic CPP hydrogel with alkali TTCP powder during the setting
mechanism at ambient temperature produces such an interaction. Clearly, dissolution of embedded
TTCP particles within CPP hydrogel develops a continuous interaction until the TTCP particles
convert into P-DCPD. From physical and microscopic scale aspects, we expect a mesh-like
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hydrogel matrix within the porous cement structure. Molecular structural of P-DCPD determines
its mechanical and cohesiveness superiorities to classical CPC since it was composed of
interconnected P-DCPD crystal particles by interlocking to the polyphosphate chains, while CPC
is composed of DCPD crystal particles with weak monomer to monomer binding.

5.3 Materials and Methods
5.3.1 P-DCPD and DCPD particle preparation
P-DCPD and DCPD cement were prepared based on previously mentioned protocol,
briefly; P-DCPD cement was prepared by mixing of CPP gel with TTCP (weight ratio of 1:0.87,
w/w) at room temperature. The mixture of CPP gel with TTCP powder is dough-like material
which was placed into a cylindrical mold with an inner diameter of 6 mm. In addition, DCPD
cement was prepared by mixing β-TCP, Monocalcium phosphate monohydrate [Ca(H2PO4)2 H2O]
(MCPM) (weight ratio of 1:0.812), and 19.1 ml of 0.05 M citrate acid. The mixed material was
pressed to yield a cylindrical specimen by uniaxial pressing for 10 days at room temperature. After
cement dried, they were ground to the fine powders using mortar and pestle. The ground particles
were evaluated under the microscope for particle size analysis (<75 µm).
P-DCPD and DCPD particles (<75 µm).were divided into 4 parts each, collected in plastic Petri
dishes. A total of 8 samples were incubated in 37 ºC for 1, 4, 7, 14 days respectively. The first
sample from each category was collected after 24 h (1st day) and placed under the hood to dry. The
second sample from each category was collected after 96 h( 4th day) and placed under the hood to
dry, and the procedure was repeated until 14 days. After all samples were collected the further
analysis was performed on the particles.
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5.3.2 Phase determination of DCPD and P-DCPD using X-Ray Diffraction (XRD)
A Rigaku SmartLab Ultima IV x-ray diffractometer with a Cu Kα X-ray source was used
to measure diffraction peaks for each sample. Approximately 0.5 g of sample powder was loaded
into the glass sample holder and flattened at the top. Data were captured every 2° between 10° and
80° at a rate of 5°/second. Analysis of XRD data was completed using PDXL 2.4.2.0 software and
samples were referenced by DB card. % crystallinity.
X-Ray Diffraction (XRD) was used to characterize the phases of DCPD and P-DCPD at
different time interval and XRD of DCPD powders were shown in Figure 5.1. DCPD at 1-day
sample represented most of the peaks of brushite [HCa(PO4).(H2O)2:] and some of the peaks of
tuite [Ca3(PO4)2]. Small intensity peaks combined brushite and tuite peaks. Some single
component tuite and very few hydroxylapatite peaks were also observed.

Figure 5.1. XRD peaks of DCPD and P-DCPD powders for 1, and 14 days of incubation
considering the best figure of merit (FOM), DCPD particles represent brushite with ICDD# 04013-3344.

74

5.3.3 Setting reaction mechanism study of DCPD and P-DCPD using Raman spectroscopy
Raman Spectra were gathered using a Renishaw inVia Raman Microscope with 50x NPlan Lecia optics (Numerical aperture=0.75) and a working distance of 0.75mm. The 785nm
excitation beam was reduced to 10% power (approximately 11.5mW). The powder was
compressed into thin disks to achieve a solid surface for the collection interface and scanned using
three-second accumulations for each point in a range of 200-1500 cm-1. Five points were taken on
each sample and averaged to compensate for a small radius of each collection point on the sample.
Raman spectroscopy was used to characterize the setting reaction mechanism of P-DCPD at
different time intervals after mixing of ACPP and TTCP. Raman further supports the formation of
DCPD and transition from initial materials to the final DCPD or HA materials, which was
explained by XRD.

Figure 5.2. Raman Spectra of DCPD and P-DCPD powders for 1, 14 days of incubation.
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5.3.4 Identification of particle morphology and content using scanning electron
microscopy(SEM)
SEM was used to collect high-resolution images of particle morphology and identify
particle contents using EDS analysis. While monomeric DCPD groups show very visible changes
in the morphology of its aggregates over time, P-DCPD groups reveal much subtler morphological
changes. Therefore, EDS analysis was an integral part of identifying particles and correlating
morphology to suspected particle status. Energy Dispersive Spectroscopy (EDS) Analysis: Using
the scoring key tolerances established by EDS negative controls, Ca/P ratios of particles were
classified as either a pure or transitional. SEM images color marked with EDS data are shown in
Figure 5.3.

a

c

b

d

▼

Figure 5.3. Morphologies of DCPD and P-DCPD with EDS data over time (a) DCPD humidified
1 day (b) DCPD humidified 14 days (c) P-DCPD humidified 1 day and (d) P-DCPD humidified
14 days

Ca/P averages were taken across both length scales without prejudice to determine key
transitional trends in major particles. It was found that while less Hydroxyapatite (HA) was
detected that the DCPD formation is higher for P-DCPD powder converge on the accepted range
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for ‘pure P-DCPD’ with longer humidification, monomeric DCPD shows higher HA formation.
Figure 5.4 illustrates the progression of the average Ca/P values over time. Additionally, Using
P-DCPD and DCPD mature particles resulted in observing less amount of material as transitioned
DCPD.

a

b

Figure 5.4. Average Ca/P ratio progression over time. (a) DCPD, (b) P-DCPD
Although it would be impossible to tell from a static timepoint whether Ca/P values in the
1.5-2.0 range represented Hydroxyapatite or the reactant β-TCP, the Ca/P trend over time suggests
that P-DCPD forms the desired product in the prolonged presence of water molecules while DCPD
formed a certain quantity of Hydroxyapatite crystals between the 4 days and 7 days timepoints.
This crossing of Ca/P ratios into the HA or DCPD/HA transitional range accompanied by the
appearance of new morphologically different aggregates (Shown in Figure 5.4) suggests the
transformation of monomeric DCPD to larger hydroxyapatite aggregates.
Conversely, it is seen that particles showing Ca/P ranges of 0.85-1.14 for P-DCPD products
become much more frequent in subsequent P-DCPD time groups. This is grounds to suspect that
P-DCPD is not as susceptible to HA transformations in the presence of water.

77

5.3.5 Stability and adhesion of DCPD and P-DCPD particles using Zeta Potential
The ζ potential of P-DCPD and DCPD in the colloidal state were measured in the aging
medium at 25 °C to determine and compare the stability and adhesion for both particles
As shown in Table 5.1 and Figure 5.5. zeta potential values for both products have a slight
descending trend in terms of approaching to a less negative value as interval time increases. The
absolute zeta potential value is less negative for P-DCPD. Basically, when P-DCPD particles are
placed in water, polyphosphate chains expose their negative charges. Since the polyphosphate
chains expected to be depleted as result of P-DCPD formation, less negative potential can be
predictable. As previously[72], indicated zeta potential value for ACPP particles was -32.92±2.74
mv, which is a more negative value in comparison to P-DCPD and DCPD. This indicates presence
of fewer polyphosphate chains in P-DCPD, as the overall potential decreases with greater numbers
of exposed asymmetric P=O-P ends.

Table 5.1. Zeta potential values for P-DCPD and DCPD in water
ζ Potential (mean ± SD) (mV)
Intervals (day)
P-DCPD

DCPD

1

-20.5

-28.60

4

-20.4

-30.5

7

-19

-28.05

14

-19.7

-23.35
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Figure 5.5. Average zeta potential values for P-DCPD and DCPD, indicating

5.3.6 Contact angle measurements
Water contact angle and absorption behavior on the surface of DCPD and P-DCPD were
measured and analyzed for 4-time intervals of particle incubation. 20 µl of deionized water was
dropped on the surface of each compressed disc (CARVER, Wabash, IN. USA) made up of DCPD
and P-DCPD particles.

Table 5.2. Water contact angle values for P-DCPD and DCPD
Sample

1-Day

4-Days

7-Days

14-Days

P-DCPD

DCPD

P-DCPD

DCPD

P-DCPD

DCPD

P-DCPD

DCPD

Angle[°]±

20.32 ±

7.12 ±

29.19 ±

24.87 ±

23.71 ±

8.35 ±

16.70 ±

8.27 ±

STD

1.03

0.13

1.22

3.23

0.10

1.25

0.67

0.42
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Figure 5.6. The water contact angle of P-DCPD vs. DCPD, indicating super hydrophilicity nature
of DCPD
As shown in Figure 5.6, DCPD and P-DCPD contact angle results (< 30 °) confirms the
hydrophilicity of both materials. DCPD with contact angle (< 20 °) shows super hydrophilic
behavior. To further investigate how hydrophilicity degree of two materials varies in different time
points; an experiment was performed to measure the alteration of contact angle during the
absorption period.

Table 5.3. The water absorption rate for P-DCPD and DCPD
PDCPD

DCPD

Sample
dθ/dt

STD

dθ/dt

STD

1D

1.411

0.540

3.079

1.115

4D

0.944

0.237

1.004

0.414

7D

1.635

0.087

3.532

1.126

14D

1.296

0.058

8.000

3.020
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Figure 5.7. Water absorption behavior for DCPD and P-DCPD in 1 day, 4 days, 7 days, and 14
days after incubation.
As it has shown in Figure 5.7 absorption rate for P-DCPD is lower than DCPD and it can
be considered near-constant, overall. DCPD has a higher absorption rate, with an increased
absorption rate over time of incubation. P-DCPD particles considered polymeric material, which
known as material with less hydrophilicity degree over other monomeric materials.
A t-test was used to determine the statistical difference in the absorption rate between DCPD and
P-DCPD particles (P<0.05).

5.4 Data Analysis
All the experiments were repeated 3 times for each group for different time intervals and were
summarized. Zeta potential and contact angle experiments were expressed as mean ± SD. A t-test
was used to determine the statistical difference in the absorption rate between DCPD and P-DCPD
particles (P<0.05).
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5.5 Discussion
The self-setting reaction is initiated by mixing of monomeric acidic monocalcium
phosphate (MCPM) and basic calcium phosphates (TTCP) in an aqueous solution, which
undergoes setting in a continuous dissolution–precipitation reaction. P-DCPD is set by a
synchronous gelation–polymerization process by the reaction of an aqueous acidic ACPP gel with
alkali TTCP powder at ambient temperature. The key molecular structural difference between PDCPD and DCPD are the interconnected P-DCPD crystal particles via interlocking polyphosphate
chains, compared to DCPDs crystal particles with weak mutual bonding.
In this chapter, we compared the physio-chemical and micro-structural performance of PDCPD and DCPD particles. We found that P-DCPD was more stable than DCPD and showed
much less transformation to hydroxyapatite crystals in a neutral reaction environment
demonstrated by XRD, SEM and Raman spectroscopy.
XRD analysis carried out by Dr. Rajib Barua, demonstrated quick and steady DCPD
formation from MCPM and β-TCP. The monomeric DCPD sample contained hydroxyapatite and
β-TCP impurities (Figure 5.1). The β-TCP impurity was likely unreacted starting material. The
hydroxyapatite impurity may have originated from the hydroxyapatite present in the β-TCP
sample, as an impurity from the synthesis of β-TCP. It is also possible that DCPD decomposed to
hydroxyapatite, due to its weak mutual bonding and absent chain formation. Thus DCPD was
unstable and acts as a precursor of hydroxyapatite. The P-DCPD sample contained a mixture of
DCPD, troemelite, monetite and trace hydroxyapatite. P-DCPD likely decomposed to troemelite,
monetite and traces of hydroxyapatite. The trace amount of hydroxyapatite suggests that P-DCPD
decomposes to hydroxyapatite very slowly. Therefore, it exhibits greater stability than its
monomeric counterpart, DCPD. P-DCPD first dehydrates and forms monetite, CaHPO4. Since
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monetite is still present, the P-DCPD is in the process of removing water molecules from their
structure. Troemelite peaks are observed a much higher than hydroxyapatite means that P-DCPD
forms troemelite higher than that of hydroxyapatite. Monomeric DCPD forms a high quantity of
hydroxyapatite. P-DCPD is observed during a slow formation of bone cements. The reaction rate
cannot be clearly identified due to a visible shrinkage of P-DCPD particles during the comparison.
Therefore, the other characterization techniques were used to observe additional finding in addition
to XRD analysis.
Raman intensities of DCPD indicated the partial formation of DCPD along with the peak
of reactants and hydroxyapatite. This hydroxyapatite appears from the reactants and from the
decomposition of DCPD due to their unstable nature. Therefore, the analysis by Raman
spectroscopy supports the XRD studies. The conversion to hydroxyapatite is more pronounced in
DCPD as compared to the conversion to hydroxyapatite in P-DCPD. The phenomenon can be
rationalized by the chain formation in P-DCPD. The acidic reactant of P-DCPD mainly acts as a
setting reactant due to its unique inter/intra polyphosphate chains. As shown in Figure 5.2, at the
beginning of the setting, the main bands obtain are vs (P-O-P), vs (PO2) and the band between 12901355 cm-1 from ACPP gel and ν series from TTCP. With the time elapse, vs (P-O-P) and vs (PO2)
becomes broader and shifts to a high wavenumber to accumulate more calcium ions from TTCP.
However, the third band (1290-1355 cm-1) shows TTCP peaks which indicates unreacted TTCP in
P-DCPD. The results deviate in this part may be due to processing difficulties. This phenomenon
indicates the possibility to obtain a double phase in P-DCPD. One phase contains regular P-DCPD
with lacking calcium ions in their structure and the other phase contains unreacted TTCP with the
high calcium content. This phenomenon may change the physicochemical properties of P-DCPD
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explained elsewhere. However, this newly formed P-DCPD has higher stability than monomeric
DCPD as the existence of hydroxyapatite is not observed.
In the SEM studies, performed by our Master’s student, Conor Daly-Seiler, a small amount of
transforming hydroxyapatite, absence of transformed hydroxyapatite and a significant decrease in
Ca/P ratios in P-DCPD were observed (Figure 5.3). These indicate that P-DCPD is more stable
than DCPD. SEM studies suggest a fundamental difference in the formation of DCPD and PDCPD particles although both follow the same dissolution-precipitation mechanism. The decrease
in DCPD structure and formation of transitioning and transitioned hydroxyapatite confirms their
lack of stability. DCPD particles exhibit a very weak mutual bonding because reactants do not
form any interconnection and interlocking of the interconnected chains which increases their rate
of reaction. P-DCPD, on the other hand, tends to transform slowly after mixing reactants because
an intermediate precursor phase of P-DCPD is formed. During precipitation, the newly formed PDCPD crystals grow, while interconnecting and interlocking the entangled polyphosphate chains.
Although it would be impossible to tell from a static timepoint whether Ca/P values in the 1.52.0 range represented hydroxyapatite or the reactant β-TCP, the Ca/P trend over time suggests that
P-DCPD forms the desired product in the prolonged presence of water molecules while DCPD
formed a certain quantity of hydroxyapatite crystals over time. This crossing of Ca/P ratios into
the hydroxyapatite or DCPD/hydroxyapatite transitional range accompanied by the appearance of
new morphologically different aggregates suggests the transformation of monomeric DCPD to
larger hydroxyapatite aggregates.
As it has shown in Figure 5.5, we also noticed that the Zeta potential of P-DCPD (-19.9
mV) was lower than that of DCPD (-27.6 mV). The key engineering factor for the change in zeta
potential is the presence of polyphosphate chains in P-DCPD. Zeta potential represents the stability
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of DCPD and P-DCPD particles. DCPD indicates more stability than P-DCPD because they
exhibit a more negative zeta potential than that of P-DCPD particles. When these particles are
placed in water, the particle surface exposes positively charged Ca2+ and negatively charged
phosphates (e.g. monomeric phosphate for DCPD and polyphosphate for P-DCPD particles).
DCPD obtains a higher negative value which indicates more negative adsorption of calcium ions.
On the other hand, P-DCPD has a low negative value which indicates less adsorption of calcium
ions because calcium ion needs time to adsorb in polyphosphate chains. Therefore, the Ca/P ratio
in P-DCPD is lower than that of DCPD in the specific time period. This result is consistent with
the EDS studies.
Another interesting finding is that the contact angle of P-DCPD (8.27°) is lower than that
of DCPD (16.71°) (Figure 5.6, Table 5.2). The lower the water contact angle, the higher the
hydrophilicity, wettability, and water absorption rate. DCPD provides a less contact angle than PDCPD because DCPD, being super-hydrophilic undergoes faster dissolution than P-DCPD in an
aqueous environment. The weak bonding in DCPD allows positively charged calcium ions
dissolute fast. P-DCPD, on the other hand indicates high contact angle because highly entangled
and interconnected polyphosphate chains in P-DCPD let calcium ions to dissolve slowly in
aqueous solution. Therefore, a higher Ca/P ratio in DCPD than that of P-DCPD obtained from
EDS study result can support the contact angle studies as well.

5.6 Conclusion and Future Work
DCPD exhibits a faster formation than the P-DCPD. Reactants exhibit a fast chemical reaction
and form DCPD along with hydroxyapatite and β-TCP impurities. This hydroxyapatite may
originate from reactant β-TCP or may decompose from DCPD due to the unstable nature of DCPD.
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P-DCPD exhibits a slow and stable chemical reaction to form troemelite, DCPD, monetite and
traces of hydroxyapatite. The amount and intensity of hydroxyapatite peaks are substantially lower
in P-DCPD as compared to their monomeric counterparts. Conversion to hydroxyapatite is more
pronounced in monomeric DCPD than in P-DCPD due to the unstable nature of DCPD.
The Raman spectroscopy supports the XRD studies of the appearance of hydroxyapatite. The
formation of the polyphosphate chain in P-DCPD reduces the conversion of hydroxyapatite. Peak
broadening and shifting of ACPP accumulate more calcium from TTCP in their polyphosphate
chain and improve the stability in P-DCPD. DCPD shows the existence of hydroxyapatite through
a high Ca/P ratio but P-DCPD does not indicate the existence of hydroxyapatite. SEM results
support the Raman spectroscopy and XRD studies.
A high electronegative zeta potential states initial fast adsorption of calcium ions in DCPD
during setting reaction. P-DCPD indicates slower adsorption of calcium ions in polyphosphate
chains. DCPD’s super hydrophilicity causes faster dissolution of the material than that of P-DCPD
in aqueous environment and low cohesion of the matrix upon washout. Thus, the hydrogen ions
will be more available in the solution and therefore the pH reduces quickly. Inversely, P-DCPD
possesses a polymeric nature, where the chain entanglements enhance the integrity of P-DCPD,
thereby the pH remains stable for longer period of time.
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CHAPTER 6

Biocompatibility Comparison of the P-DCPD and DCPD Particles in Vitro and in Vivo

6.1 Purpose and Hypothesis
Several factors such as surface charge, microporosity, composition and changes of
molecular composition, affect osteoblast cell adhesion and migration process to the surface. Based
on the results from physiochemical differences between DCPD and P-DCPD (Chapter 5), it is
expected that cells behave differently in terms of proliferation and differentiation on each material.
Based on unique properties of P-DCPD and DCPD, mouse air pouch tissue represents different
inflammatory responses.

6.2 Introduction
Interaction of cell and tissue with a material surface is the subject of this chapter. The
surface properties directly influence the cellular response, ultimately affecting the rate and quality
of new tissue formation. Initially, molecules from the surrounding fluid start to adsorb and create
a conditioned interface to which the cell can attach. The macroscopic morphology, as well as the
microscopic features and chemical composition of the surface, determine which molecules can
adsorb and how cells will attach and align. In bone and cartilage tissue, osteoblasts are highly
sensitive to subtle differences in surface roughness and chemistry. The aforementioned properties
on the surface will have direct consequences on cell attachment, proliferation, and differentiation.
Osteoblasts derived from MSCs. Their function is the synthesis of collagen and several
additional specialized proteins. Besides MSCs, osteoblasts are also widely used to study the
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influence of Ca-P materials on cell response, such as their attachment, proliferation and secreting
function. MC3T3-E1 has been used as classical cell models for detection of osteoblastic
differentiation stimulated by biomaterials [153, 154]. Generally, osteoblasts tend to attach more
and spread better on osteoinductive Ca-P, and their secretion of ALP, as well as some osteoblastic
differentiation markers, are also promoted by these materials. For example, according to the
microarray analysis, the phenotype of mouse MC3T3-E1 osteoblasts was significantly altered by
Ca-P with varied phase composition, especially the increased ALP activity and mRNA expression
of ALP, COL-I and OPN [155].Therefore osteoblasts are the best in vitro testing model.
Calcium polyphosphate (CPP) is an inorganic polymeric bioceramic. Due to its low Ca:P
ratio, CPP has a long chain-like molecular structure and is easily hydrolyzed into calcium
orthophosphate. In contrast to the classical CPC setting formula (reaction of monomeric acid
calcium source with alkali calcium source), to prepare injectable and self-setting P-DCPD cement
by the reaction of CPP gel with tetracalcium phosphate (Ca4(PO4)2O; TTCP), we used CPP gel
as the acidic calcium source. In previous studies from our research group, we found that P-DCPD
cement formed by CPP gel denotes a new formulation of CPC with some advantages over classical
cement such as strong mechanical strength and excellent cohesion to the bones. In the final chapter
of this dissertation, my goal is to examine how does biocompatibility of P-DCPD differs from
DCPD particles in terms of osteoblast proliferation and differentiation. As such, the question that
arises here is that if the differences observed in particle comparison study can effect in Vitro cell
biocompatibility and in Vivo tissue absorption?
To determine the inflammatory potential of P-DCPD and compare it with DCPD particles,
we are going to subcutaneously inject both materials in the mouse air pouch model developed by
Edwards et al. [156]. This model allows us to examine changes in the pouch tissues induced by
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the treatment. In addition, the effect of newly developed cement formula; P-DCPD bone graft
substitutes; in this pouch model have not been investigated. The host response was evaluated by
pouch tissue histology (H&E stains).
In vitro tests provide rapid results for predicting or screening the biocompatibility of
materials. They allow a high level of control over the test environments in contrast to in vivo tests
in which animal or human subjects may be influenced by variables such as sex, age, activity, diet,
etc.
The standard cell biocompatibility testing recommended by the US Food and Drug
Administration (FDA), established by ISO 10993 and ASTM F748, which has been designed for
testing cured materials. These tests measure the cytotoxicity of material by determining metabolic
activity via MTT assay.
Several studies on calcium phosphates have shown that cellular response depends on many
factors, such as dissolution, composition, topography, and surface energy.
Depending on the calcium phosphate dissolution–precipitation behavior osteoblast
function can be affected, in their proliferation, differentiation, and maturation [157-159]. De Bruijn
et al showed that there is a connection between dissolution rate and early bone formation in vivo
and the osteogenic differentiation in vitro of osteoprogenitor cells, suggesting, therefore, the
influence of free calcium and inorganic phosphates on bone formation [160]. Studies show that
calcium and phosphate concentrations of the environment may increase or decrease when calcium
phosphate ceramics are immersed. This may be induced by immersing calcium phosphate ceramics
can even induce cell death [161]. Changes of calcium or phosphate contents in culture medium
also affect directly the osteoblastic activities [162].
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From the topographical aspect, grooved calcium phosphate surfaces influence the
osteoblastic guidance and the groove profile independently of the nature of the substrate (Lu and
Leng 2003). Moreover, osteoblasts can feel the microporosity and macroporosity of calcium
phosphate surface and they act accordingly [163]. For osteoblasts differentiation, Chou et al have
shown that MC3T3 cells are highly sensitive to the crystal shape: large apatite crystals induced
more bone than small apatite crystals after 3 weeks of culture [164].
Considering surface energy as an important feature of surface, it strongly affected the initial
osteoblastic activity for proliferation and function, while at a later time the less favorable surface
exhibited a comparable osteoblastic activity to the most favorable surface [165].
To assess CPC biocompatibility, in vitro studies using the cement in a bulk form or in a
very large particle size form have been performed [166, 167]with different cell types. CPC was
well tolerated by the bone cells and could enhance the production of different bone proteins.
Regarding osteoblast cells interaction with calcium phosphates, osteoblasts are intimately in
contact with calcium phosphate surfaces thanks to the production of extracellular collagen firmly
attached perpendicular or parallel to the substrate[168] .
Physicochemical dissolution kinetics of the bio-material: calcium phosphate ceramics do
not all interact in the same way with osteoclasts. The release of calcium ions from the biomaterial
seems to play a critical role in the osteoclastic activity; above a critical range of calcium ions
levels, osteoclastic resorption is inhibited [169].Together with the dissolution behavior, the
structure of the calcium phosphate ceramic and the crystallinity influence the osteoclastic activity.
CPP’s cellular response has been investigated in several studies from the polymeric point
of view as well as physical aspects. A study has been focused on how hydrolytic group percentage
affects cellular response as result of degradation [62]. Wang et. al. showed that by increasing
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sintering temperature, the proportion of Q1 groups in polyphosphate chain decreased. Based on
their cell viability test results, the porous CPP did not exert cytotoxicity effect on the cells after
being cultured for nearly 6 days. Due to the lower degradation rate, CPP sintered at higher
temperatures showed better cell attachment and proliferation as well as higher cell density.
Furthermore, from a physical point of view, in previous studies from our group crystalline
CPP scaffold has been subjected to in vitro cell studies. In an in vitro study, both homogeneous
and gradient CPP scaffolds made by compressing methods from CPP powder [170]. To study cell
differentiation and proliferation the samples were soaked in murine preosteoblastic MC3T3-E1
cell suspension. No significant difference in cell proliferation was found between the gradient and
the homogenous calcium polyphosphate scaffolds, however a much higher cell differentiation and
mineralization were observed in the gradient calcium polyphosphate scaffolds than the
homogenous calcium polyphosphate scaffolds, which demonstrated by increased alkaline
phosphatase activity. The improved distribution and differentiation of cultured cells within
gradient scaffolds were reported. Therefore, gradually increasing pore sizes and interconnectivity
provided a favorable microenvironment for the migration, differentiation, and in vitro
mineralization of cultured cells.
As previously discussed, based on differences in physicochemical properties of DCPD and
P-DCPD, surface chemistry and morphology was altered. As such, there is no doubt that cellular
attachment, proliferation, and differentiation will be affected. Ren et. al. [171] have demonstrated
the setting mechanism of P-DCPD. They proposed that the setting mechanism of P-DCPD is
completely different from the classical calcium phosphate cement (CPC) that achieves
crystallization by monophosphates reaction. In previous Aim, a comparative study was done on
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how the setting mechanism of P-DCPD is different from DCPD, due to intermolecular interaction
between acidic CPP and alkali tetracalcium phosphate (TTCP).
Here, our goal is to examine P-DCPD and DCPD cell differentiation, proliferation and
cytotoxicity capacity and drive a conclusion based on physicochemical parameters. As such, the
question that arises here is that if the differences observed in previous chapters can effect on in
Vitro and in Vivo biocompatibility studies?
Previously, the presence of EM loaded strontium‐doped calcium polyphosphate (SCPP)
particles in pouch models were tested and they found that particles increase the air pouch
membrane thickness, and the number of macrophages in the pouches as well as the cytokine
production [172].
However, CPP or P-DCPD, purely, has not been investigated in such an experimental
procedure before. Calcium phosphate cement (CPC) has been investigated [173], in vivo
experiments on rabbits demonstrated that brushite was resorbed and replaced by newly formed
bone within 3 months. During CPC resorption, particle debris was noted around the periphery of
the cement. Intracellular accumulations of brushite cement were also apparent in phagocytes. In
another study, mineral grains had become detached from the cement and some of them had been
phagocytosed by macrophages. These grains were round in shape and did not exceed 12 µm.
As such, in this case, we design and perform a mouse air pouch model to investigate
inflammatory response of pouch tissue to the new material and compare it with CPCs.
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6.3 Materials and Methods
All chemicals used for preparation and analysis were of analytical grade and obtained
from Sigma‐Aldrich if not stated otherwise. Murine MC3T3‐E1 pre-osteoblast cell line was from
ATCC (Manassas, VA), Alpha‐modified minimum essential medium (α‐MEM) and phosphatebuffered saline (PBS) was purchased from Gibco, Life Technologies. 24-well culture plate was
obtained from Falcon™ (3047), and 96 well plates were purchased from Fischer Scientific. MTT
and cytotoxicity detection (LDH) kits were purchased from ATCC, Manassas, VA, and Roche
Diagnostics, Indianapolis, IN, USA, respectively.

6.3.1 Particle preparation
In order to make P-DCPD particles, CPP gel was prepared by mixing the ACPP powder (<
75 μm) with distilled H2O (0.05 g/mL) and stirring at room temperature for 1.5 h. The CPP slurry
mixture was allowed to stand overnight for gel formation. Polymeric DCPD (P-DCPD) cement
was prepared by mixing of ACPP hydrogel with tetracalcium phosphate (TTCP) powder (weight
ratio 1: 0.87: 0.15, w/w) in the presence of sodium citrate at room temperature. The dried P-DCPD
bone cement was ground into the fine powders (< 75 μm). Finally, samples were sealed and placed
inside the desiccator for further experiments.
Monomeric DCPD cement was prepared by mixing of 10 g β-TCP, 8.127 g calcium
phosphate monobasic monohydrate (MCPM), Ca(H2PO4)2.H20 (Sigma-Aldrich, St. Louis, MO)
and 19.1 ml 0.05M citric acid (Sigma, cat# C8532) at room temperature. The mixture was ground
into fine powders (< 75 μm). Finally, samples were sealed and placed inside the desiccator for
further experiments.
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6.3.2 Particle sterilization
The prepared particles were sterilized by submerging them into 70 % ethanol for 1 h, the
after 1 h residual ethanol was removed by centrifuging the particles and replacing it by phosphatebuffered saline (PBS obtained from Gibco, Life Technologies). The PBS was centrifuged and
replaced three times, and finally particles were immersed in cell culture medium (α-MEM obtained
from Gibco, Life Technologies) prior to adding to the cells. The process was done right before
seeding particles on the cells.

6.3.3 Cell culture
MC3T3-E1 cells were used to determine the biocompatibility of P-DCPD and DCPD
particles. Cells were maintained in cell culture flasks (25 cm2) with α-MEM containing 10% fetal
bovine serum (FBS), and 1 % penicillin in an incubator (37 °C, 5% CO2, and 98% humidity) and
were passaged every 5 days. To passage cells, the cell culture flasks were washed with PBS and
1ml trypsin was added to detach cells from the bottom of the flasks. The cell-based assays were
run as summarized in Table 6.1.

Table 6.1. MC3T3-E1cells were treated by P-DCPD and DCPD particles undergone 3 cell-based
assays to determine proliferation, differentiation, and toxicity
Experiment Purpose

Assay

Mitochondrial Activity (Proliferation)

MTT

ALP activity (Differentiation)

AKP

Cytotoxicity

LDH
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(a)
1 µg/ml

(b)

DCPD
5 µg/ml

10 µg/ml

1000 µg/ml

P-DCPD

Figure 6.1. MC3T3-E1 cells treated with particles. (a) DCPD and (b) P-DCPD particles

6.3.4 Cell Proliferation
Cell seeding
To prepare samples for the MTT assay, cells of passage numbers 10–20 were used. About
2 × 105 MC3T3 cells (5-15 passage number) (40 % confluency) in 500 μL of culture medium (αMEM obtained from Gibco, Life Technologies) were seeded into each well of a 24-well culture
plate (Falcon™ Polystyrene Microplates, #3047) and were incubated in a 5% CO2 atmosphere
overnight at 37°C so that the cells could adhere.
Particle seeding
Particles in 1, 5, and 10 µg/ml concentrations were added to cells. 5, 25, 50 µl of stock
particle suspension (100 µg/ml) were added to the 495, 475, and 450 µl of seeded cells into each
well, respectively. Final concentrations to test were 1, 5, 10 µg/ml.
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay
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Cell

viability

was

determined

using

MTT

(3-(4,5-dimethylthiazol-2-yl)-2,5-

diphenyltetrazolium bromide) assay (ATCC, Manassas, VA, 30-1010K) in 3 d and 7 d after
particle seeding. 20 µl of MTT reagent was added to each well and plate was incubated at 37 °C
for 2 h. After 2 h, all the media was removed and the 100 % DMSO was added to neutralize the
effect of reagent (add until the cells become colorless at the bottom of well). Before performing
MTT the 300 µl of culture media was removed from each well and then stored in the freezer for
toxicity experiment. The morphology of the cells adhered to the bottom of well was observed with
a Zeiss optical microscope (US ZEISS, Brighton, MI) equipped with a Toshiba CCD.

6.3.5 Cell differentiation
Cell seeding
MC3T3-E1 cells (early passage numbers) were seeded in semi-confluency (20 %) before
any treatment. Following 3 d of culture, differentiation was started by culturing cells in
differentiation medium (α-MEM supplemented with ascorbic acid, glycerophosphate) 24 h before
adding particles. The medium was replaced with fresh medium and in the next d the particles were
added. Each time the media were reserved in the freezer for further toxicity experiments. The
process was repeated every 3 days until at least 14 days, then cells were analyzed for ALP
expression by digesting cells.
Particle seeding
DCPD and PDCPD particles were sterilized by UV and 1, 10,100, 1000 µg/ml
concentrations were added to each well, 24 h after culturing with differentiation medium.
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Alkaline phosphatase activity (cell differentiation)
ALP is an important stain to determine cell differentiation. To induce MC3T3-E1 cell
differentiation, the differentiation medium was supplemented with 0.2 mM ascorbic acid and bGlycerphosphate in 10 mM concentration. After culturing 14 days, the cells with particles (ALP
assay buffer 50 µl/well) were harvested to collect lysate for the ALP assay according to the
manufacturer’s protocol.

6.3.6 Cell toxicity
Lactate dehydrogenase (LDH) assay (cytotoxicity assay)
To prepare samples for the LDH assay, cells of passage numbers 10–20 were used. The
previously preserved media before cell proliferation studies (300 µl) was used to run a cytotoxicity
detection kit (Roche Diagnostics, Indianapolis, IN, USA).

6.3.7 In Vivo implantation of injectable particles using animal air pouch model
The animal procedure was done in Providence hospital by Ascension research group. Air
pouches were established on 48 mice by subcutaneous injection with 2.5 ml air (Figure 6.3). After
six days, the animals were divided into 6 groups of 8 mice (Table 6.2); they were anesthetized by
intraperitoneal injection of pentobarbital (120 mg/kg) and xylazine (10 mg/kg) (Fisher Scientific,
Pittsburgh, PA). The particles, with less than 15 µm of diameter were injected into the air pouch
tissue.
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Table 6.2. Study Design and Mice Group
Group

n

Harvest

I

8

7 days

Treatment
PBS (saline/control)

1 month
II

8

7 days

P-DCPD

1 month
III

8

7 days

DCPD

1 month

Mice were sacrificed in 7days and 1 month after implantation (Figure 6.2). Pouch tissues
were collected and washed with 0.5 mL sterile PBS.

Figure 6.2. Mice were sacrificed and the pouch tissue was collected for histological analysis. The
pictures are showing the tissue collection from mice (Mouse air pouch tissue collection and
experiments were carried out in Ascension orthopedic research lab at Providence Hospital).
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Figure 6.3. Schematic outline of the air pouch model. At the start of the test, 2.5 mL air is injected
through a sterile 0.20 μm filter at a dermal site of a mouse to form a pouch.

6.3.8 Histological Analysis of Air Pouch Tissue
Histological evaluations were performed to investigate any presence of inflammation in air
pouch tissue resulting from particles in the area. To this goal pouch, tissue samples were fixed in
10% formalin and processed for paraffin embedding. Tissue sections (6 µm) were stained with
hematoxylin & eosin (H&E) to evaluate pouch membrane morphology. Four separate sections per
specimen were evaluated in a blinded fashion. Digital images were acquired using a light
microscope, and these images were analyzed using the Image Pro image analysis software package
(Media Cybernetics, Silver Spring, MD). Pouch membrane thickness were determined at six points
on each section, with an even distribution of measurement on the proximal side, distal side, and
transition curve of the pouch. The total number of cells (based upon nucleus count) were analyzed.

6.4 Data analysis
Data were analyzed with excel. All values were expressed as mean ± standard deviation.
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Statistical significance was set to p < 0.05. The experiments were repeated 3 times for 2 groups
(DCPD and P-DCPD), so a total of 6 experiments were performed for the MC3T3-E1 cell line. All
the variables were summarized and expressed as mean ± SD. Statistical significance of the results
was determined by excel for differences among 2 groups. p<0.05 were considered statistically
significant.
For the in vivo part, data were analyzed with excel. All values are expressed as mean ± SD.
Statistical significance was set to p < 0.05. The experiment was done for 8 mice for each group
(DCPD and P-DCPD), so a total of 8 experiments were performed for mouse air pouch model, and
within each experimental procedure such as LDH the samples were triplicated. All the variables
were summarized and expressed as mean ± SD. Statistical significance of the results was
determined by excel for differences among 2 groups. p<0.05 were considered statistically
significant.

6.5 Results
6.5.1 Cell Proliferation
Cell proliferation in the presence of 3 doses of DCPD and PDCPD particles was
determined by MTT assay and shown in Figure 6.4 at 2-time points. During the time that cells
were underexposure of particles in different doses, cell growth was determined by MTT assay.
There was a general increase in cell number with time, indicating that both types of cement support
cell proliferation (Figure 6.4) While the cell growth in presence of 5 µg/ml of DCPD is
significantly different than 1 and 10 µg/ml of P-DCPD, there is no significant difference in cell
growth between different particle dose of P-DCPD comparing control in 3 days.
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In 3rd day of testing cell growth, DCPD and P-DCPD are significantly different for 5 and 10 µg/ml,
while 7 days after particle seeding, cell growth in presence of DCPD and PDCPD is not
significantly different unless for the cells in presence of 5 µg/ml particles.
Overall, cells exposed to P-DCPD grow more in 3 d in compare with DCPD exposed cells
regardless of particle dose. Although cell proliferation was significantly inhibited by 5, and 10
µg/ml of P-DCPD particles in 7 d the growth of DCPD exposed cells is normal in comparison with
control in 7 d. And in 7d the P-DCPD growth is still higher than DCPD for 1 µg/ml dose.

DCPD

MTT Assay (OD 570 nm)

2.5

P-DCPD

2
1.5

1
0.5
0
Ctrl.

1

5

10

1000 Ctrl.

1

5

10
3D

1000
7D

Figure 6.4. MTT assay results of MC3T3-E1 cells cultured by P-DCPD and DCPD particles with
concentrations of 1, 5, 10, and 1000 µg/ml for 3and 7 days.

6.5.2 Cell Differentiation
To determine the effects of DCPD and P-DCPD particles on MC3T3-E1 differentiation,
intracellular ALP activity was measured. As shown in Figure 6.5, the ALP activity of both
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particles in each concentration group is significantly lower than control (P <<0.05). The decrease
in ALP activity is highly significant in the cells which were treated by DCPD (P <<0.05). ALP
activity of P-DCPD particles are not statistically significant as compared to untreated cells

Normalized AKP concentration
(nmol/mg/ml)

(control).

30

**

DCPD
**

**

25

PDCPD

**
**
**

20

*

**

15
10
5
0
Ctrl.

1
10
100
1000
Particle concentration (µg/ml)

Figure 6.5. Normalized ALP activities of MC3T3 cells cultured with DCPD and P-DCPD particles
in 1, 10, 100, and 1000 µg/ml plus Control. Cells were cultured on a well plate. OD of sampled
were read on 405 nm, n = 4, *p<0.05, **p<0.005.

6.5.3 Cell Toxicity
Toxicity assay of DCPD and PDCPD particles in four concentrations for 3d and 7 d was
shown in Figure 6.6. The LDH activity of DCPD treated cells is significantly higher when they
were treated for a longer period of time (7 days). In 3 days of culturing DCPD treated cells the
LDH activity of 10, and 1000 µg/ml groups are significantly higher. Moving forward to P-DCPD
treated cells, except 1000 µg/ml P-DCPD treated cells for 7 days of culturing period, none of PDCPD treated groups show significant LDH activity as compared to untreated cells.
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Overall, LDH leakage is significantly higher in 7 d than 3 d for DCPD, however, and it is not the
case for PDCPD and LDH amount is lower in 7 d time point.
DCPD

P-DCPD

Figure 6.6. LDH activity of MC3T3-E1 cells in the presence of 1, 5, 10, and 1000 µg/ml DCPD
and P-DCPD particles for culturing duration of 3 and 7 days.

6.5.4 Quantitative Analysis of Histological Slides
P-DCPD and DCPD particles induced a similar level of pouch tissue inflammation and
membrane thickness in 1 week. In 1 month the inflammatory cells increased significantly for PDCPD loaded tissue as compared with saline control and DCPD loaded tissues. The inflammation
significantly reduced after 1 month for control and DCPD loaded mouse tissue while there is no
significant difference between 1 week and 1-month tissue inflammation for P-DCPD loaded airpouch membrane. H&E staining (Figure 6.8) revealed that both particles do not significantly
stimulate membrane thickness and the number of infiltrating cells in pouches for 1 week of
treatment, as compared to saline controls. However, the quantitative image analysis of histological
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sections revealed that in 1 month the membrane thickness reduced significantly for DCPD treated
membrane after 1 month, as well as saline controls.

Cellular Infiltration

Membrane Thickness
0.16

**

*

*

Cellular infiltration (per mm2)/1000

Membrane Thickness (mm)

0.18

**

0.14
0.12
0.1
0.08
0.06
0.04
0.02
0
PBS

DCPD
1 Week

5

*
*

**

*

*

4
3
2
1
0

P-DCPD

1 Month

PBS

DCPD
1 Week
1 Month

P-DCPD

Figure 6.7. Quantitative image analysis of mouse
air-pouch tissue treated by P-DCPD and DCPD particles for 1 week and 1 month. Membrane
thickness analysis (a), cellular infiltration analysis (b). The data was compared to control mouse
groups which were treated only by injecting sterilized PBS.
The membrane thickness reduced by time in case of DCPD and saline controls tissue but the PDCPD loaded membrane does not show a significant reduction in membrane thickness by passing
time. Membrane thickness is significantly larger then DCPD and control in 1 month of treatment.
P-DCPD loaded tissue shows higher integrity upon loading the particles.
Cellular infiltration reduced by the course of time in both control and DCPD cases but for P-DCPD
the cellular infiltration didn’t change significantly. However, the infiltration increased
significantly as compared to control in 1-month time course.
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PBS

DCPD

P-DCPD

7D

1
M

Figure 6.8. Representative pouch tissues histology of microscopic appearance. All the tissue
sections stained with hematoxylin and eosin (H&E). (Original magnification, 20x).

6.6 Discussion
P-DCPD and DCPD particles similarly affect cell growth, but growth of P-DCPD treated
cells slightly were affected by adhesion of the particles and reduced the growth in some cases for
P-DCPD. Moderately hydrophilic P-DCPD with less negative surface charge in compare with
DCPD must be more favorable substrate for cells. Thus, P-DCPD shows promising cell
differentiation (Figure 6.5) as compared to DCPD. Also, P-DCPD induced much lower toxicity,
even for higher concentrations up to 1000µg/ml. Super hydrophilic nature of DCPD is effecting
the cellular adhesion and thus the cell differentiation and growth. In addition, DCPD is highly
negative particle, based on Chapter 5, and zeta potential data showed that P-DCPD is less negative.
Cellular proliferation all depends on degree of hydrophilicity and positive charge of the
surface [174], thus the higher cellular viability of P-DCPD is due to the impact of moderate
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hydrophilicity and lower negative charge of the surface. At the same time P-DCPD’s fast adhesion
to the surface can be a problematic matter since the cells face some barriers in their path, thus the
viability might be affected. Thus far, P-DCPD is a favorable material for cells in terms of toxicity
and differentiation. Slight reduce in cell growth in presence of P-DCPD can be due to some
material properties such as pH. However, it has been tested that DCPD and P-DCPD maintained
at similar pH (~7), it is worthy to note that P-DCPD consists of acidic component such as CPP
hydrogel which might be dissolved poorly while making the cement or it might be exposed to the
surface of the particles. This acidity can interfere with the results of cell culture.
In Vivo study, the control, P-DCPD and DCPD particles induced similar cellular
infiltration in a 1-week time point however for 1-month time point the cellular infiltration reduces
as compared to 1-week results but as compared to control the P-DCPD calls more cells to the
membrane. From the cellular response one can estimate that P-DCPD and DCPD must have a
similar inflammation and membrane thickness profile at least for the shorter time point. The 1week results fully confirm the idea. For the 1 month as the particles remain inside the pouch
membrane, P-DCPD induces more inflammatory response as compared to both control and DCPD
which might be due to the interaction of tissue with P-DCPD. On the other hand, P-DCPD is
polymeric material that can make a shelter for bacteria to grow [175] and induce inflammatory
results in the host tissue therefor as particles remain for the longest time within tissue, it might
generate higher cellular infiltration for P-DCPD as oppose to DCPD and control.
6.7 Conclusion and Future Work
In conclusion, based on preliminary results obtained from Chapter 5, P-DCPD with
moderate hydrophilicity and absorption rate, as opposed to super hydrophilic DCPD showed
higher viability for cell proliferation and differentiation.
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According to the higher dissolution rate and less cohesion of DCPD matrix, and the
increase of Ca and P in material extracts, less favorable differentiation and toxicity results of
DCPD–treated materials were observed. Overall, P-DCPD showed more favorable environment
for cells to proliferate and remain viable.
Based on in vivo experiments, as it has been noted before an inflammatory response can
be caused by several factors. The main factor which is highly distinguishable between P-DCPD
and DCPD is matrix adhesion. This can be related to the dissolution rate for both matrices when
they are embedded in air pouch tissue. Based on Song et al findings, it is expected that P-DCPD
with higher matrix adhesion properties, induced less or no inflammatory response than DCPD
embedded sample. In this chapter we showed that P-DCPD and DCPD similarly act in pouch tissue
for 1-week and then P-DCPD induce some negligible inflammation as compared to saline control
and DCPD-treated mice. Moreover, morphological properties of DCPD and P-DCPD are
determinant factors for evaluating tissue response to the embedded particles. P-DCPD as a
polymeric bone cement material acts as a shelter for bacteria to grow as it remains for longer time
within the tissue.
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ABSTRACT
INVESTIGATION OF PHYSIOCHEMICAL PROPERTIES AND BIOCOMPATIBILITY
OF AMOURPHOS CALCIUM POLYPHOSPHATE HYDROGEL DOPED WITH
ANTIBIOTICS AND INJECTABLE P-DCPD BONE CEMENT
by
YASAMAN CHEHREGHANIANZABI
MAY 2020
Advisor: Dr. Weiping Ren
Major: Biomedical Engineering (Tissue Engineering)
Degree: Doctor of Philosophy
Amorphous calcium polyphosphate (ACPP) is an inorganic polymer ceramic. Here we use
a simple method of preparing ACPP hydrogel in the presence of excess volume of water.
Essentially, water availability to polyphosphate chains accelerates water molecule ingress and
microstructural transformation of ACPP hydrogels. Antibiotic delivery capacity of ACPP hydrogel
increases by the specific mixing and molding method, where the vancomycin (VCM) an
erythromycin (EM) have higher antibiotic encapsulation efficiency with the small burst release for
the compressed discs as compared to VCM and EM release from manually molded discs. Also
VCM demonstrates higher efficacy upon encapsulation and interaction with acidic ACPP
hydrogel, where EM’s sensitivity was disrupted.
In part of this study, we investigate impact of ACPP hydrogel replacement by monomeric
calcium phosphate on the quality of final product (dicalcium phosphate dihydrates (DCPD)
cement). The physiochemical properties of polymeric bone cement as compared to classical bone
cement were determined. Moreover, antibacterial activity of Polymeric Dicalcium Phosphate
Dihydrate (P-DCPD) cement is one crucial step toward insuring material viability for avoiding the
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bacterial growth. Thus in vitro bactericidal experiment shows the potency of P-DCPD material
and selected antibiotics to invade bacteria and the correlation of the results with the antibiotic
activity results from ACPP hydrogel discs. For further advancement of P-DCPD material, an in
vitro and in vivo biocompatibility study of the cement particles reveals the effect of
physicochemical properties of the cement on cellular and tissue viability.
We believe that the formation of ACPP hydrogel is through the mechanisms of
intermolecular ionic interaction and entanglement of polyphosphate chains affect drug retention
within the matrix in a favorable way. As such, some of the surface physiochemical properties such
as cement cohesion may affect cellular and tissue response. P-DCPD shows similar or even
superior biocompatibility than classical/monomeric DCPD. In the future, the drug-eluting capacity
of polymeric DCPD will be investigated to correlate it with the obtained results from ACPP
hydrogel.
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